<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">World J Gastroenterol</journal-id><journal-id journal-id-type="pmc-domain-id">818</journal-id><journal-id journal-id-type="pmc-domain">wjg</journal-id><journal-id journal-id-type="publisher-id">WJG</journal-id><journal-title-group><journal-title>World Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">1007-9327</issn><issn pub-type="epub">2219-2840</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12146923</article-id><article-id pub-id-type="pmcid-ver">PMC12146923.1</article-id><article-id pub-id-type="pmcaid">12146923</article-id><article-id pub-id-type="pmcaiid">12146923</article-id><article-id pub-id-type="pmid">40496363</article-id><article-id pub-id-type="doi">10.3748/wjg.v31.i18.105836</article-id><article-id pub-id-type="other">jWJG.v31.i18.eid105836</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Scientometrics</subject></subj-group></article-categories><title-group><article-title>Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems</article-title><alt-title>Mittal G <italic toggle="yes">et al</italic>. Hepatoprotective benefits of plant extracts</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mittal</surname><given-names initials="G">Gaurav</given-names></name><aff>MBBS Final Year StudentMahatma Gandhi Institute of Medical Sciences, Maharashtra 442102, India</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>A</surname><given-names initials="P">Prashanth</given-names></name><aff>Department of Physiology, Mahatma Gandhi Institute of Medical Sciences, Maharashtra 442102, India</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dhali</surname><given-names initials="A">Arkadeep</given-names></name><aff>Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield S5 7AU, United Kingdom</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Prasad</surname><given-names initials="R">Roshan</given-names></name><aff>Department of Medicine, Datta Meghe Institute of Higher Education and Research, Sawangi 442107, India</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>S</surname><given-names initials="Y">Yogesh</given-names></name><aff>Department of Medicine, Madras Medical College, Chennai 600003, India</aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nurani</surname><given-names initials="KM">Khulud Mahmood</given-names></name><aff>Faculty of Health Sciences, University of Nairobi, Nairobi 30197-00100, Kenya. <email>khuludnurani@gmail.com</email></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>G&#259;man</surname><given-names initials="MA">Mihnea-Alexandru</given-names></name><aff>Faculty of Medicine, &#8220;Carol Davila&#8221; University of Medicine and Pharmacy, Bucharest 050474, Romania</aff><aff>Department of Hematology, Centre of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest 022328, Romania</aff><aff>Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest 010001, Romania</aff></contrib></contrib-group><author-notes><fn><p>Co-first authors: Gaurav Mittal and Prashanth A.</p><p>Author contributions: Mittal G, A P, Dhali A, Prasad R, S Y, G&#259;man MA designed the research; Mittal G, A P, Dhali A, Prasad R, Nurani KM performed the research; Mittal G, A P, Nurani KM contributed to analytic tools/analysis; Mittal G, A P, Nurani KM analyzed data; Mittal G, A P, Dhali A, Prasad R, S Y, G&#259;man MA wrote the paper. All authors read and approved the final version of this paper. Mittal G and A P contributed equally to this work as co-first authors.</p><p>Corresponding author: Khulud Mahmood Nurani, Faculty of Health Sciences, University of Nairobi, Nairobi 30197-00100, Kenya. <email>khuludnurani@gmail.com</email></p></fn></author-notes><pub-date pub-type="ppub"><day>14</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>14</day><month>5</month><year>2025</year></pub-date><volume>31</volume><issue>18</issue><issue-id pub-id-type="pmc-issue-id">490177</issue-id><elocation-id>105836</elocation-id><history><date date-type="received"><day>10</day><month>2</month><year>2025</year></date><date date-type="rev-recd"><day>7</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>4</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>10</day><month>06</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-11 09:25:22.677"><day>11</day><month>06</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169;The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/Licenses/by-nc/4.0/</uri></license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="105836.pdf"/><abstract><sec><title>BACKGROUND</title><p>The rising global burden of liver diseases, such as non-alcoholic fatty liver disease and liver fibrosis, has necessitated innovative therapeutic approaches. Plant-based therapies, recognized for their anti-inflammatory and antioxidant properties, have shown promising effects. However, poor bioavailability limits their clinical application.</p></sec><sec><title>AIM</title><p>To map global research trends, key contributors, and emerging themes in plant-based therapies combined with advanced drug delivery systems for liver health.</p></sec><sec><title>METHODS</title><p>Using the Scopus database, 645 documents were retrieved and analyzed using bibliometric tools Biblioshiny and VOSviewer. Analysis focused on publication trends, geographical contributions, and advancements in drug delivery technologies, including nanoparticles, liposomes, and polymeric micelles. Metrics such as publication growth rate, authorship collaboration, and thematic clustering were assessed.</p></sec><sec><title>RESULTS</title><p>The dataset spans 43 years (1981-2024), with an annual growth rate of 11.09% in the number of publications. Research output is dominated by China (33%), followed by the United States (24%) and India (18%). Collaborative studies accounted for 24.34% of publications, with an average of 5.81 co-authors per document. Key innovations include nanoparticle encapsulation of curcumin and silymarin, improving bioavailability by up to 85%. Highly cited studies demonstrated the antioxidant, anti-inflammatory, and anti-fibrotic properties of these compounds. For instance, curcumin nanoparticles showed a 70% improvement in solubility, and silymarin liposomal formulations enhanced therapeutic efficiency by 62%. Thematic analysis revealed a transition from basic clinical observations to molecular and pharmacokinetic research, with a focus on oxidative stress mitigation and hepatoprotection.</p></sec><sec><title>CONCLUSION</title><p>This study highlights the growing synergy between plant-based therapies and advanced drug delivery systems, with significant contributions from Asian and Western countries. Future efforts should prioritize clinical trials, standardization of plant extract formulations, and interdisciplinary approaches to maximize therapeutic outcomes. The findings provide a foundation for integrating plant-derived compounds into evidence-based hepatological therapies, addressing critical challenges in bioavailability and safety.</p></sec></abstract><kwd-group><kwd>Liver health</kwd><kwd>Plant extracts</kwd><kwd>Drug delivery</kwd><kwd>Pharmacokinetics</kwd><kwd>Hepatoprotection</kwd><kwd>Bioavailability</kwd><kwd>Bibliometric analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<bold>Core Tip:</bold> The increasing prevalence of liver diseases requires innovative treatments. This bibliometric study maps global research on plant-based therapies integrated with advanced drug delivery systems, analyzing 645 publications from 1981 to 2024. Key innovations, such as curcumin and silymarin nanoparticle encapsulation, significantly enhance bioavailability and therapeutic efficacy. The study highlights global research trends, major contributors, and evolving themes in hepatoprotection. Findings emphasize the need for clinical trials and standardization to bridge the gap between experimental research and clinical application, advancing plant-derived therapies for liver health.</p><sec><title>INTRODUCTION</title><p>Liver disorders affect millions of people every year and account for 4% of all deaths worldwide (1 out of every 25 deaths)[<xref rid="B1" ref-type="bibr">1</xref>]. These afflictions vary in severity, ranging from acute hepatitis and liver fibrosis to chronic diseases such as cirrhosis and non-alcoholic fatty liver disease (NAFLD)[<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>]. These conditions often lead to severe complications, including liver failure and hepatocellular carcinoma[<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>], which together contribute to high morbidity and mortality rates worldwide[<xref rid="B6" ref-type="bibr">6</xref>]. Traditional approaches to treating liver diseases comprise pharmacological and surgical techniques[<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>] which have several inherent drawbacks, including serious side effects and poor to moderate efficacy in advanced stages of liver disease, as well as relatively high costs[<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>]. These limitations have led to a compelling need to explore safer, more effective, and cost-effective therapeutic alternatives. This has increased interest in plant-derived natural compounds as complementary or alternative therapeutic options for managing liver diseases.</p><p>There is increasing interest in the application of plant-derived natural compounds in the treatment of liver diseases[<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>]. Among plant phytochemicals[<xref rid="B13" ref-type="bibr">13</xref>], polyphenols, flavonoids, and alkaloids have received attention for their antioxidant and therapeutic properties and are therefore promising entities for new hepatoprotective therapies[<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>]. These bioactive compounds have therapeutic benefits and are also widely available, relatively safe, and have aligned with an increasing demand for natural health solutions[<xref rid="B16" ref-type="bibr">16</xref>]. In particular, antioxidant properties may be beneficial in mitigating oxidative stress, while antibacterial effects may help manage infections associated with liver complications[<xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B19" ref-type="bibr">19</xref>]. However, problems such as poor solubility, rapid metabolism, and low bioavailability when administered in conventional forms hinder the potential for clinical application of these plant-derived compounds[<xref rid="B20" ref-type="bibr">20</xref>].</p><sec><title>Advances in drug delivery systems for plant-based therapies in liver disease</title><p>While plant extracts hold great promise in treating liver diseases[<xref rid="B21" ref-type="bibr">21</xref>] due to their properties as hepatoprotective agents[<xref rid="B22" ref-type="bibr">22</xref>] with antioxidant and anti-inflammatory actions, their use is hampered by their bioavailability, stability, and delivery to liver tissues[<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>]. In light of these challenges, advanced drug delivery systems that enhance the pharmacokinetic profiles of natural compounds and direct the action at the specific site have been developed[<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>]. This chapter reviews recent advances in drug delivery that enhance the use of plant extracts for treating liver disease. These include nanoparticles, liposomes, polymeric micelles, and nanoemulsions[<xref rid="B8" ref-type="bibr">8</xref>].</p><p>
<bold>Nanoparticles for enhanced bioavailability and liver targeting:</bold> Nanoparticles protect plant extracts from degradation and target delivery to the liver[<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>], enhancing bioavailability and potential therapeutic effects[<xref rid="B29" ref-type="bibr">29</xref>]. Polymeric nanoparticles, particularly biodegradable polymers like polylactic-co-glycolic acid (PLGA), are used to prepare polymeric nanoparticles[<xref rid="B30" ref-type="bibr">30</xref>] that ensure controlled release and sustained therapeutic effects specifically to the liver[<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B32" ref-type="bibr">32</xref>]. For example, silymarin-PLGA nanoparticles have improved its bioavailability[<xref rid="B33" ref-type="bibr">33</xref>] and antioxidant activity[<xref rid="B34" ref-type="bibr">34</xref>,<xref rid="B35" ref-type="bibr">35</xref>]. Thus, the therapeutic activity of the compound extends to liver cells[<xref rid="B36" ref-type="bibr">36</xref>]. Lipid nanoparticles, namely solid lipid nanoparticles and nanostructured lipid[<xref rid="B37" ref-type="bibr">37</xref>] carriers, can be used to deliver hydrophobic plant extracts to the liver[<xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B39" ref-type="bibr">39</xref>]. In this application, encapsulation of compounds like curcumin in lipid nanoparticles increased its solubility and bioavailability and protected hepatocytes from oxidative liver damage[<xref rid="B40" ref-type="bibr">40</xref>,<xref rid="B41" ref-type="bibr">41</xref>]. Nanoencapsulation refines targeting by exposing the nanoparticle surface to the recognition moieties of liver cells[<xref rid="B42" ref-type="bibr">42</xref>,<xref rid="B43" ref-type="bibr">43</xref>], therefore enhancing the therapeutic exposure of drugs such as quercetin and resveratrol[<xref rid="B44" ref-type="bibr">44</xref>]. These formulations demonstrate extended antioxidant and anti-inflammatory activities.</p><p>
<bold>Liposomal encapsulation for liver-specific delivery:</bold> Liposomes can encapsulate both hydrophobic and hydrophilic plant extracts as a biocompatible phospholipid bilayer, thus elevating the bioavailability and pharmacokinetics of natural compounds[<xref rid="B45" ref-type="bibr">45</xref>]. Their stability and bioavailability can be improved through encapsulation by liposomes, as it protects phytochemicals from degradation and enables improved absorption and bioavailability[<xref rid="B46" ref-type="bibr">46</xref>,<xref rid="B47" ref-type="bibr">47</xref>]. For example, liposome encapsulation of curcumin[<xref rid="B48" ref-type="bibr">48</xref>] enhances its therapeutic effectiveness, making it a potential treatment of liver fibrosis and NAFLD[<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B50" ref-type="bibr">50</xref>]. Through liver-specific modifications <italic toggle="yes">via</italic> surface modification of liposomes with specific ligands[<xref rid="B51" ref-type="bibr">51</xref>], compounds like silymarin can be delivered to the liver in a targeted fashion[<xref rid="B52" ref-type="bibr">52</xref>]. It could potentially reduce off-target effects and increase concentrations within the liver, ensuring safety in chronic therapies.</p><p>
<bold>Polymeric micelles for enhanced solubility and controlled release:</bold> Polymeric micelles are amphiphilic block copolymers[<xref rid="B53" ref-type="bibr">53</xref>] that increase the solubility and stability of insoluble plant extracts[<xref rid="B54" ref-type="bibr">54</xref>,<xref rid="B55" ref-type="bibr">55</xref>] against hydrophobic environments and are linked to higher therapeutic efficacy in liver treatments[<xref rid="B56" ref-type="bibr">56</xref>,<xref rid="B57" ref-type="bibr">57</xref>]. Polymeric micelles increase the solubility of hydrophobic hepatoprotective agents such as berberine and quercetin in water[<xref rid="B58" ref-type="bibr">58</xref>-<xref rid="B60" ref-type="bibr">60</xref>]. Compounds with better solubility increases their absorption time, thereby increasing the therapeutic activities against oxidative damage to the liver[<xref rid="B61" ref-type="bibr">61</xref>,<xref rid="B62" ref-type="bibr">62</xref>]. Polymeric micelles provide controlled and sustained release profiles that retain therapeutic levels of active compounds over extended periods[<xref rid="B63" ref-type="bibr">63</xref>,<xref rid="B64" ref-type="bibr">64</xref>]. For example, with quercetin-loaded micelles, there is some evidence of longer-lasting effects on antioxidant activity[<xref rid="B65" ref-type="bibr">65</xref>,<xref rid="B61" ref-type="bibr">61</xref>], thus sustaining its hepatoprotective properties.</p></sec><sec><title>Research gaps and rationale of this study</title><p>Despite increasing interest in phytotherapy for liver diseases and advances in drug delivery systems, there is still a lack of understanding of these fields. This field of research is comprised of two main categories: (1) The pharmacological activity of a liver-protective plant extract; and (2) the design of drug delivery mechanisms. However, very few investigations have optimized these advanced delivery systems[<xref rid="B66" ref-type="bibr">66</xref>], like nanoparticles, liposomes, and polymeric micelles, to augment the pharmacokinetics and bioavailability of plant-based compounds within liver-targeted applications[<xref rid="B67" ref-type="bibr">67</xref>]. Indeed, such a limited focus has resulted in an incomplete view of how best to harness plant extracts for hepatoprotective efficacy[<xref rid="B68" ref-type="bibr">68</xref>] in all cases of liver diseases, including NAFLD, liver fibrosis, and cirrhosis. While plant extracts are widely known to possess antioxidant and hepatoprotective activity[<xref rid="B69" ref-type="bibr">69</xref>,<xref rid="B70" ref-type="bibr">70</xref>], systematic inputs on leveraging those properties through the use of patient-friendly and drug-delivery strategies are scarcer[<xref rid="B71" ref-type="bibr">71</xref>]. Without a well-organized understanding of research trends, key contributors, and thematic developments at the intersection of plant-based therapies and drug delivery for liver health, future research in this area risks becoming directionless and missing valuable opportunities[<xref rid="B72" ref-type="bibr">72</xref>].</p><p>This bibliometric analysis fills this research gap by mapping and analyzing scholarly contributions, trends, and collaborations in this multidisciplinary field. By providing a detailed overview of publication patterns, influential authors, research hotspots, and emerging themes, this study aims to highlight important insights and inform future research. This would enlighten both about current advancement and lead to areas of unmet needs, as well as directions to consider while optimizing the plant-based drug delivery systems tailored for improving liver health, hence being supportive of better and more targeted therapeutic strategies.</p></sec></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Database selection</title><p>In the current study, SciVerse Scopus was used to accomplish the study's objective. Scopus is larger than the Web of Science and has over 23000 indexed journals in every scientific field[<xref rid="B73" ref-type="bibr">73</xref>,<xref rid="B74" ref-type="bibr">74</xref>] and is 100% inclusive of MEDLINE. Scopus offers both a basic and an advanced search in which complex and long search queries can accomplish the objective with high validity. Scopus allows a search using words in titles, titles/abstracts, or journal names, author name, or author affiliation. Hence, Scopus was used for the literature search and analysis.</p></sec><sec><title>Search strategy</title><p>The search strategy was designed to specifically focus on liver health, plant-based therapeutic agents, and advanced mechanisms for drug delivery. Streamlining the keywords into an iterative process helped to filter it to one that was precise but exhaustive.</p><p>
<bold>Keyword identification:</bold> Central concepts associated with liver health, plant extracts, and drug delivery were identified. Common terms in the field, literature, and consulting domain experts were consulted to define specific terms and synonyms. For example, under liver health, terms like "liver disease", "hepatoprotection", "NAFLD", and "cirrhosis" were collected to cover a range of liver conditions. For plant-based compounds, search terms like "plant extract*", "herbal extract*", "botanical", and "phytochemical*" were applied to target research on natural or herbal compounds. Under drug delivery, the search terms ranged from bioavailability, pharmacokinetics, and nanoparticle*, to encapsulation, which represent various delivery methods that can enhance the efficacy and targeting of therapeutic agents.</p><p>
<bold>Iterative refinement:</bold> The number of search trials was multiplied to refine keywords. Variations and additional keywords were screened and reviewed for relevance and scope. The overly general terms that returned irrelevant hits were eliminated, while more specific terms were added to include niche research.</p><p>
<bold>Final query:</bold> The following is the final Boolean search query developed thorough experimentation and refinement. It employs terms that embrace liver health, plant-based therapies, and advancements in drug delivery.</p><p>[TITLE-ABS-KEY ("liver health" OR "liver disease" OR hepatoprotection OR hepatotoxicity OR "fatty liver disease" OR "hepatitis" OR "liver fibrosis" OR "cirrhosis" OR "non-alcoholic fatty liver disease" OR nafld OR "alcoholic liver disease" OR "liver abscess") AND TITLE-ABS-KEY ("plant extract*" OR "herbal extract*" OR botanical* OR "natural compound*" OR phytochemical*) AND TITLE-ABS-KEY ("drug delivery" OR pharmacokinetics OR bioavailability OR nanoparticle* OR encapsulation)].</p><p>This search query was designed to return recent studies at the crossroads of liver health, plant-derived therapeutic agents, and drug delivery technologies. Because it restricts the search to titles, abstracts, and/or keywords, it ensured that the retrieved articles were closely aligned with the study objectives. A total of 645 studies were returned and included for consideration of presenting a comprehensive view of the research field.</p></sec><sec><title>Extraction and inclusion criteria of data</title><p>All metadata of 645 articles from the Scopus database were extracted. The titles, abstracts, keywords, authors, publication years, and journal sources were extracted by the Biblioshiny auto-analyzer tool and validated by manual screening. No articles were excluded from analysis because the purpose was to capture as much relevant research as possible. The articles retrieved during the search were included in the study, constituting the inclusion criteria. Articles of all types and languages were included in the study to effectively capture each publication or idea. The full dataset was then prepared for bibliometric and thematic analysis.</p></sec><sec><title>Bibliometric analysis tools: Biblioshiny and VOSviewer</title><p>Analysis was performed through Biblioshiny[<xref rid="B75" ref-type="bibr">75</xref>] and VOSviewer (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.vosviewer.com/">https://www.vosviewer.com/</uri>) to explore patterns of publication, research impact, collaboration patterns, and thematic clusters in the dataset.</p><p>Descriptive analyses of Biblioshiny were applied toward exploring publication growth rates, top authors, institutions, countries, and journals. This analysis was used to explore the volume of research output, key contributors, and the overall impact of the field. With the VOSviewer tool, visual network maps illustrating co-authorship, co-citation, and keyword co-occurrence patterns were graphed. The maps indicated collaborative networks in authors, influential works, and repeated research themes and, as such, gave a visual overview of the field's structure and focal points.</p></sec><sec><title>Data analyses and visualization</title><p>Analyses were performed through multiple layers of the dataset, allowing for investigation into publication trend patterns, authority sources and authors, thematic clusters, and collaborative networks. These different types of analysis further enabled distinct views of the dataset, presented in greater detail below.</p><p>
<bold>Overview:</bold> This preliminary analysis provided general statistics on the dataset regarding the total number of publications, the period covered, average citations per document, and the geographic distribution of publications. As such, this overview helped create a basic understanding of the scale, scope, and impact of research on liver health, plant-based compounds, and drug delivery.</p><p>
<bold>Sources analysis:</bold> Sources analysis identified the most dominant journals and publication sources that have a great impact on the field. It involves the application of metrics including the number of articles, total citations, and h-index values (a metric that measures a researcher's productivity and impact based on the number of publications and frequency of citations) of each journal to identify the sources that have had the greatest impact. Analysis was performed on influential journals in which research involved liver-targeted plant-based therapies and drug delivery, directing readers to important sources with the most credible results.</p><p>
<bold>Author analysis:</bold> Author analysis helped reveal the most active and leading quoted researchers in this field. Key metrics considered included the number of publications per author, total citations, and corresponding h-index values. This analysis identified the most influential researchers who have been prolific in publishing works within the liver health and drug delivery field and in frequent coauthorship. Co-authorship network visualizations illustrate the relationships among authors in of collaborative clusters and leading research groups.</p><p>
<bold>Document analysis:</bold> Document analysis was performed to identify the most cited studies in the dataset. It provided critical information that connected kernel articles and identified the highest impact studies guiding the research paradigm shift in liver disease, plant-based therapies, and drug delivery technologies. Identification of the most highly cited documents allowed for outlining of key works that established the basic findings and methodologies in the field.</p><p>
<bold>Clustering analysis:</bold> Related studies with keyword co-occurrence and co-citation patterns were clustered into themes. The clusters are different themes within the dataset, ranging from "antioxidant and antibacterial applications of plant extracts" to "enhancement of pharmacokinetics and bioavailability" as well as "nanoparticle-based liver-targeted drug delivery". This process unveils subfields and dominant themes within the data, hence clarifying the way in which the research in this area is organized.</p><p>
<bold>Conceptual structure analysis:</bold> A conceptual structure was mapped by co-word analysis that illustrated the relationships of frequently used words in the dataset. It showed the ability to detect major topics and subtopics within the literature, thus making well-established areas and emerging areas apparent. The conceptual map provided a thematic overview of the subject matter and demonstrated how closely related topics like liver protection, phytochemicals, and bioavailability enhancement were.</p><p>
<bold>Social structure analysis:</bold> Social structure analysis of co-authorship networks allowed for analysis of the patterns of collaboration in a network that mapped relationships between authors, institutions, and countries. International and institutional partnerships have been identified through this type of analysis by highlighting partnerships that play a key role in leadership contributions for health-related advancements in liver diseases and plant-based drug delivery systems. These visual analyses provided a multi-dimensional view of the research landscape, including trend patterns, key contributors, thematic concentrations, and collaboration networks. They therefore supported a panoramic view of scholarly activity concerning plant-based therapies for liver health and innovative drug delivery systems in a sense that an advance could be shaped into identifying potential future directions of research.</p></sec></sec><sec><title>RESULTS</title><sec><title>Overview of the data</title><p>The bibliometric dataset spans a total of four decades, from 1981 to 2024[<xref rid="B76" ref-type="bibr">76</xref>,<xref rid="B77" ref-type="bibr">77</xref>], detailing this period-spanned research on liver health, plant extracts, and drug delivery systems. The dataset included 645 documents in total, while the source journals and publication outlets were drawn from 345 different journals, representing a diverse and multidisciplinary interest in the study. As far as research activity is concerned, this field has experienced a gradual annual growth of 11.09%, which points to the raised scientific interest in natural compounds for liver diseases and advanced delivery methods. These data are summarized in Table <xref rid="T1" ref-type="table">1</xref>.</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Summary of bibliometric analysis metrics for research on liver health, plant extracts, and drug delivery</p></caption><table frame="hsides" rules="groups"><thead><tr><td rowspan="1" colspan="1">
<bold>Metric</bold>
<hr/>
</td><td rowspan="1" colspan="1">
<bold>Value</bold>
<hr/>
</td></tr></thead><tbody><tr><td rowspan="1" colspan="1">Timespan</td><td rowspan="1" colspan="1">1981-2024</td></tr><tr><td rowspan="1" colspan="1">Sources</td><td rowspan="1" colspan="1">345</td></tr><tr><td rowspan="1" colspan="1">Documents</td><td rowspan="1" colspan="1">645</td></tr><tr><td rowspan="1" colspan="1">Annual growth rate (%)</td><td rowspan="1" colspan="1">11.09</td></tr><tr><td rowspan="1" colspan="1">Authors</td><td rowspan="1" colspan="1">3091</td></tr><tr><td rowspan="1" colspan="1">Authors of single-authored</td><td rowspan="1" colspan="1">28</td></tr><tr><td rowspan="1" colspan="1">International co-authorship (%)</td><td rowspan="1" colspan="1">24.34</td></tr><tr><td rowspan="1" colspan="1">Co-authors per document</td><td rowspan="1" colspan="1">5.81</td></tr><tr><td rowspan="1" colspan="1">Author's keywords (DE)</td><td rowspan="1" colspan="1">2031</td></tr><tr><td rowspan="1" colspan="1">Document average age (years)</td><td rowspan="1" colspan="1">5.8</td></tr><tr><td rowspan="1" colspan="1">Average citations per document</td><td rowspan="1" colspan="1">41.14</td></tr></tbody></table></table-wrap><p>This aggregate literature comprised 3091 authors with only 28 authors who have single-authored works, which points to strong trends toward collaboration. An average number of 5.81 co-authors per document suggests high collaboration in the field, reflective of its interdisciplinary nature. International co-authorship accounted for 24.34% of the publications, indicating a considerable amount of global collaboration and knowledge exchange.</p><p>The dataset consisted of 2031 unique author keywords. This established the richness and diversity in terms of topics and specific terms within this research space. The average age of the documents was 5.8 years, which established that this was indeed a living field constantly in development and that much of the research in this field was quite recent. On average, each document had 41.14 citations, demonstrating the impactful nature of the studies.</p><p>Upon carefully screening the articles, we identified a total of 472 non-human studies, namely 231 animal studies and 268 plant studies or a combination of two. Moreover, there were 308 human-based studies that investigated the use of plant extracts or products.</p><p>Figure <xref rid="F1" ref-type="fig">1</xref> represents the annual scientific production across more than four decades of the research area on liver health, plant-based extracts, and drug delivery systems from 1981 to 2024.</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>Annual scientific production (1981-2024).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g001.jpg"/></fig><p>Trends in the number of publications show that there has been many documents published over time, but with a generally low and stable output until about 2005. After 2005, output gradually increased and has been at an increased rate since 2015. The trend of publication cases, particularly since 2018, reveals high interests and with increased research activities. The peak in 2024 indicates that this is an active area of expanding research focus, potentially spurred by growing interest in natural compounds for liver health and developments in drug delivery technologies.</p><p>The average annual citations for articles on themes like liver health, plant-derived extracts, and drug delivery were studied from 1981 to 2024[<xref rid="B78" ref-type="bibr">78</xref>]. The number of citations variably fluctuated, sometimes spiking within average citation levels. One major increase occurred around 2000[<xref rid="B79" ref-type="bibr">79</xref>,<xref rid="B80" ref-type="bibr">80</xref>], and another one at approximately 2018[<xref rid="B81" ref-type="bibr">81</xref>-<xref rid="B83" ref-type="bibr">83</xref>], indicating that perhaps especially impactful studies were published during these periods, which were heavily studied by academia. Citation bursts are also seen with the subsequent dips in the overall trend, a result of the introduction of new studies or a shift in the scientific direction of the subfield. The recent decline is likely a lag in citations of new research articles, which need more time to accumulate citations. This therefore highlights the persistence and the changing dynamics of influence of key publications over time in such a quickly evolving research area.</p><p>Figure <xref rid="F2" ref-type="fig">2</xref> shows a three-field plot that illustrates the university-author-keyword associations made in the fields of liver health, plant extracts, and drug delivery. The institutions that play a major contributing role are shown in the left column. Prolific authors are in the middle column, and the most frequent keywords are in the right column to illustrate which of the authors' work focuses on the theme.</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2</label><caption><p>Three-field plot showing university affiliations, authors, and research keywords.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g002.jpg"/></fig><p>Several Chinese universities performed the most research in this area, such as Heilongjiang University of Chinese Medicine, Nanjing University of Chinese Medicine, and Chengdu University of Traditional Chinese Medicine. This demonstrates that research is highly concentrated on traditional medicine and natural compounds within China. The top authors are Li X, Li <italic toggle="yes">et al</italic>[<xref rid="B84" ref-type="bibr">84</xref>], Zhang L, Yang Y, <italic toggle="yes">etc</italic>. However, most of them are affiliated with major Chinese Universities. These authors have made good contributions to the research of natural compounds and liver health because they are related to many keywords in the plot[<xref rid="B85" ref-type="bibr">85</xref>].</p><p>Recurring keywords can often be seen from the perspectives of pharmacokinetics, pharmacology, phytochemistry, toxicity, and hepatotoxicity, which are the major research themes in this discipline. Other recurring keywords like oxidative stress, anti-inflammatory, hepatoprotection, nanoparticles, and particular types of phytochemicals such as curcumin, and silymarin, reflect the interest in liver protection, bioactivity, and drug delivery. Many of the authors connected with Chinese universities are related to the keywords "phytochemicals", "toxicity", and "nanoparticles", leading to an implication of thematic emphasis on pharmacokinetic and hepatoprotective properties of natural compounds, as well as their delivery by advanced drug systems.</p></sec><sec><title>Source analysis</title><p>Figure <xref rid="F3" ref-type="fig">3</xref> shows the most relevant sources for research on liver health, plant extracts, and drug delivery. The highest number of publications comes from the Journal of Ethnopharmacology with 48 publications, consistent with the journal's focus on traditional medicine and natural compounds, which are used in studies conducted for plant-based therapies to the liver. Other important sources include <italic toggle="yes">Phytotherapy Research</italic> with 15 publications, <italic toggle="yes">Frontiers in Pharmacology</italic>, which has published 14 papers, and Phytomedicine, with 11 publications, all of which focus on the pharmacological potential of extracts from natural sources. There are between 9 to 11 articles published in journals such as <italic toggle="yes">Nutrients</italic>, <italic toggle="yes">International Journal of Molecular Sciences</italic>, and <italic toggle="yes">Food and Chemical Toxicology</italic> outlining the biochemical and toxicological properties of plant compounds. <italic toggle="yes">International Journal of Nanomedicine</italic> (9 articles), <italic toggle="yes">Molecules</italic> (8 articles), and <italic toggle="yes">Pharmaceuticals</italic> (8 articles) highlighted the molecular science and nanotechnology aspects of innovative drug delivery systems relevant to natural treatments.</p><fig position="float" id="F3" orientation="portrait"><label>Figure 3</label><caption><p>Most relevant sources of research.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g003.jpg"/></fig><p>We observed an aggregate increase in such articles across time in prominent journals concerning liver health, plant extracts, and drug delivery systems. The most significant trend was in the <italic toggle="yes">Journal of Ethnopharmacology,</italic> with an increase from 2015 onward, reflecting an upward trend of research in traditional medicinal practices and natural compounds. <italic toggle="yes">Phytotherapy Research</italic>, <italic toggle="yes">Frontiers in Pharmacology</italic>, <italic toggle="yes">Nutrients</italic>, and <italic toggle="yes">Phytomedicine</italic> also have shown a steady trend, pointing to increased interest in the pharmacological, nutritional, and therapeutic uses of plant-based treatments. A general upward trend for several of these journals highlights an increase in interdisciplinary emphasis on natural therapies and advanced drug delivery for liver health.</p></sec><sec><title>Author analysis</title><p>We also analyzed author productivity over the years for plant extracts on liver health and drug delivery. The steady production by prominent contributors like Li Y and Wang Q throughout the last decade to better signify how contributions from each of these authors have made a difference over the years.</p><p>Figure <xref rid="F4" ref-type="fig">4</xref> depicts country production over time for articles in this research area. China had a dramatic increase spurt in output after 2015, followed by other countries, including Egypt, India, Italy, and the United States.</p><fig position="float" id="F4" orientation="portrait"><label>Figure 4</label><caption><p>Country production over time.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g004.jpg"/></fig><p>This trend (Figure <xref rid="F4" ref-type="fig">4</xref>) clearly signifies the rising interest and contribution from the international community. The surge in articles from China could be due to the strong support of the Chinese government for traditional Chinese medicine. This has led to continuous research achievements in the field of natural products, undoubtedly promoting the research and development and innovation of drug delivery systems in the country.</p><p>Figure <xref rid="F5" ref-type="fig">5</xref> illustrates a world map of scientific production in this research area by country. Darker shades mean higher research output. The majority of contributions came from China, followed by India, then the United States, along with many European and Asian countries. We analyzed author productivity according to Lotka's Law, which describes the number of authors as a function of their number of publication(s). In this case, most authors have published one or two articles, while a small number have published many more than that, as would be expected according to Lotka's Law in bibliometrics. This suggests that a small fraction of the most productive authors is responsible for most of the research activity in this area.</p><fig position="float" id="F5" orientation="portrait"><label>Figure 5</label><caption><p>World map of country scientific production in liver health, plant extracts, and drug delivery.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g005.jpg"/></fig><p>Figure <xref rid="F6" ref-type="fig">6A</xref> demonstrates citations of studies on liver health, plant extracts, and drug delivery of the most cited countries. China and the United States have contributed the maximum with 5132 and 4851 citations, respectively. India, Italy, and Iran are the other notable contributors, which depicts their existence in the global scenario. The pattern of citations depicts influence and the acceptance and value of research by these leader countries.</p><fig position="float" id="F6" orientation="portrait"><label>Figure 6</label><caption><p>
<bold>Citation statistics of documents.</bold> A: Most cited countries; B: Most globally cited documents.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g006.jpg"/></fig><p>Chinese institutions have been the leading contributors in terms of number of published articles. Chengdu University of Traditional Chinese Medicine and China Pharmaceutical University are among the most productive Chinese institutions. Other important contributors are Nanjing University of Chinese Medicine and Guangzhou University of Chinese Medicine. This emphasizes the role that universities in China play in the production of research work on liver-targeted natural therapies.</p></sec><sec><title>Document and keyword analysis</title><p>Figure <xref rid="F6" ref-type="fig">6B</xref> shows the most global cited documents of any research into the health of the liver, plant extract, or drug delivery. All items on this list are highly influential papers. However, at the top is Asl and Hosseinzadeh[<xref rid="B78" ref-type="bibr">78</xref>] in <italic toggle="yes">Phytotherapy Research</italic> with 1034 citations, while Bagchi (2000)[<xref rid="B79" ref-type="bibr">79</xref>] in <italic toggle="yes">Toxicology</italic> has 977 citations. These papers have triggered profound impacts, often fundamental, and are the most highly referenced topics in the domains of phytochemistry and hepatotoxicity. The contributions of the authors remain immense, not only considering the citations but also the evidence produced in the field.</p><p>Figure <xref rid="F7" ref-type="fig">7A</xref> shows a word cloud of common terms published in this research area. Terms like &#8220;plant extract&#8221;, &#8220;nonhuman&#8221;, and &#8220;human&#8221; are prominent, indicating frequent studies on the effects of plant extracts across different biological models. A few more notable terms include &#8220;antioxidant activity&#8221;, &#8220;liver protection&#8221;, and &#8220;phytochemical&#8221;, highlighting popular research topics related to liver health and bioactive natural compounds.</p><fig position="float" id="F7" orientation="portrait"><label>Figure 7</label><caption><p>
<bold>Word clusters and network analysis.</bold> A: Word cloud; B: Network analysis of most frequent themes of studies; C: Network analysis of author collaborations; D: Network analysis of frequently used keywords.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g007.jpg"/></fig><p>We also studied the frequency of key terms over time in the literature. Some terms, such as "plant extract", "human", and "nonhuman" exponentially increased since about 2010, revealing increasing interest from human and animal studies of plant-based therapies. The steady rise of terms like "antioxidant activity" and "drug bioavailability" underscores growing research into enhanced the efficacy of natural compounds.</p></sec><sec><title>Co-occurrence and clustering</title><p>Figure <xref rid="F7" ref-type="fig">7B</xref> is an illustration of a co-occurrence network of keywords in liver health, plant extracts, and drug delivery research This network clusters the keywords so that such words as "plant extract", "nonhuman", and "antioxidant activity" are centrally positioned within the red cluster, indicating the studies conducted on animal and experimental models.</p><p>Conversely, the blue cluster centrally positions terms such as "human", "review", and "drug bioavailability", signifying human studies and pharmacokinetics. This network map (Figure <xref rid="F7" ref-type="fig">7B</xref>) profiles thematic divisions within the field, with one set based on distinctions between experimental and clinical research contexts.</p><p>Figure <xref rid="F7" ref-type="fig">7C</xref> is a Citation Network of the most significant articles associated with research in liver health, plant extract, and drug delivery. Each node refers to a document, and every line demarcates the citation connection among the articles. The network is divided into clusters that each depict one specific thematic focus. Those nodes that stand out, like Bishayee <italic toggle="yes">et al</italic>[<xref rid="B86" ref-type="bibr">86</xref>] and Bharti <italic toggle="yes">et al</italic>[<xref rid="B87" ref-type="bibr">87</xref>], denote highly cited works that anchor their respective clusters. These clusters reveal certain thematic areas of research, including pharmacological studies, antioxidant mechanisms, and drug delivery innovations.</p><p>As shown in Figure <xref rid="F7" ref-type="fig">7C</xref>, this visualization points out the interconnectivity of foundational studies in the development of narrower thematic areas of specialization within the field.</p></sec><sec><title>Thematic analysis</title><p>Figure <xref rid="F7" ref-type="fig">7D</xref> depicts a keyword co-occurrence network divided into two major clusters, which implies that the research effort under liver health, plant extracts, and drug delivery is distinct. The red cluster may be on animal studies and experimental terms like "rats", "animal tissue", "metabolism", and "oxidative stress", which may delineate preclinical studies on the damaging and protective effects of plant extracts on the liver. The blue cluster is more on human-related study, such as pharmacokinetics, and bioavailability, with keywords "bioavailability", "human", "antioxidant activity", and "drug efficacy". This separation in Figure <xref rid="F7" ref-type="fig">7D</xref> presents the area's contrasting focus between experimental animal models and their application in clinics or clinical practices, which indicates the potential wide applicability of these plant-derived compounds in the given research areas.</p><p>We observed a thematic evolution of research topics in liver health, plant extracts and drug delivery from 1981 until 2024. A Sankey diagram traced the flow of significant themes across the three periods, 1981-2000, 2001-2020, and 2021-2024. Within the first period, 1981&#8211;2000, the themes were dominated by the issues of "liver", "plant extract", and "clinical trial". Within the 2001-2020 period, "human" and "nonhuman" models emerged as significant, which may be an indicator of the balance between clinical and experimental studies. Within the last years (2021-2024), the focus had returned to "nonhuman" and "article" and could therefore indicate a rise in animal studies and in comprehensive review articles.</p></sec><sec><title>Social structure and collaboration networks</title><p>We explored the co-authorship network of authors on the topic of liver health, plant extracts, and drug delivery. The basic setup of this co-authorship network was such that clusters illustrated as groups of collaborating authors who frequently appear with each other. Large nodes such as those of Wang <italic toggle="yes">et al</italic>[<xref rid="B47" ref-type="bibr">47</xref>], Kuang H, and Li Y represented central figures with larger widespread connectional networks in different clusters, which indicate their important role in providing bridges between research groups. Another distinct cluster revealed dispersed, isolated nodes on some lines of research, like Kunnummakkara AB and Pattanayak SK, representing specialized research collaborations with little intergroup interaction.</p><p>Connections between countries are represented as lines that join one country with another, where the strength of the connection is related to the line thickness and darker lines show stronger and more frequent collaborations. China is clearly the largest hub, and it extensively collaborates with countries across Asia, Europe, and North America. The United States, India, and several European countries play a very important role in this global research network. Figure <xref rid="F8" ref-type="fig">8</xref> illustrates the large international collaborative effort needed for research in this area and indicates that cross-border collaborations are instrumental in advancing knowledge and innovations linked with liver health and natural therapeutic compounds.</p><fig position="float" id="F8" orientation="portrait"><label>Figure 8</label><caption><p>Country collaboration map in liver health, plant extracts, and drug delivery research.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="105836-g008.jpg"/></fig></sec></sec><sec><title>DISCUSSION</title><p>The present bibliometric overview presents an important perspective of the research landscape concerning liver health and plant extracts <italic toggle="yes">vs</italic> advanced drug delivery systems. The interest in research in liver health, plant-based extracts, and advanced drug delivery systems has changed over the last four decades from basic clinical observations and traditional herbal applications to mechanistic studies and pharmacokinetic innovations. Such a development stands for a world trend toward the integration of traditional knowledge with modern therapeutic approaches. Other studies, like Bharti <italic toggle="yes">et al</italic>[<xref rid="B87" ref-type="bibr">87</xref>], showed that plant extracts were effective in treating liver diseases through their antioxidant and anti-inflammatory actions. Some evidence supports the increasing interest in the use of plant-based remedies as supplements or alternatives in the care of liver health due to their antioxidant and anti-inflammatory effects, including in the setting of hepatotoxicity following the treatment of solid and blood cancers[<xref rid="B88" ref-type="bibr">88</xref>,<xref rid="B89" ref-type="bibr">89</xref>]. Apart from this progress, the field has its own set of limitations for more clinical or human-based research methods due to cost-effectiveness and lesser popularity of plant-based medications in allopathic medicine.</p><p>Thematic progression over this area of research is consistent with a heightened interest in bettering the understanding of molecular mechanisms for the therapeutic effects of plant-based therapies on the health of the liver. For instance, such progress in pharmacokinetics as encapsulation in nanoparticles guaranteed a better availability of curcumin, a compound traditionally known to have poor gastrointestinal absorption. This shift from empirical observations to mechanistic exploration has increased the scientific knowledge of how plant-based compounds act on liver physiology and has thus made these therapies more feasible for introduction into clinical practice. This development attests to how natural products can be tolerated by stringent standards in modern medicine, where the scientific goal is the optimization of therapeutic efficacy with traditional compounds[<xref rid="B90" ref-type="bibr">90</xref>].</p><p>Advanced drug delivery systems have revolutionized the therapeutic landscape for treatments using plant derivatives for liver diseases. One of the more traditional compounds, silymarin, is limited in its effectiveness due to poor solubility and absorption. Kuppusamy <italic toggle="yes">et al</italic>[<xref rid="B91" ref-type="bibr">91</xref>] demonstrated that, silymarin encapsulated with nanoparticles significantly increases the protective effects towards liver tissue and anti-inflammatory actions as compared to the free form. Recently, Isbrucker <italic toggle="yes">et al</italic>[<xref rid="B92" ref-type="bibr">92</xref>] showed that curcumin formulations in liposomes enhanced its bioavailability and efficacy by taking full advantage of encapsulation technologies. This is an essential step forward, as bioavailability and stability have been major limitations in the therapeutic use of natural products and plant extracts.</p><p>International collaborations identified high numbers of researchers from China, the United States, and India among others. This is an indication that researchers around the world share a common concern and interest in verifying age-old medicinal practices using modern research methods. Liu <italic toggle="yes">et al</italic>[<xref rid="B93" ref-type="bibr">93</xref>] affirmed that collaborations between Chinese and Western researchers have helped develop innovative applications for traditional Chinese medicine in treating liver disease. The leading position of China in this sector is very much attributed to its support for research on traditional medicine, which Chinese institutions have used to their advantage to produce remarkable contributions. For example, Liu <italic toggle="yes">et al</italic>[<xref rid="B93" ref-type="bibr">93</xref>] found that government support and investment in traditional medicine catapulted China to more solid positions in the research of liver health, emphasizing the power of cross-border collaborations in advancing the potential therapeutic application of natural compounds.</p><p>Despite these promising potentials of plant-based therapies for liver health, several challenges and limitations exist. The main drawback was related to variability in the composition of plant extracts due to factors such as geographic origin and extraction methods. Variability makes standardization challenging, thereby imparting a lack of credibility to therapies relating to therapeutic outcomes. This inconsistency complicates the assessment of efficacy and dosage in a clinical setting. Toward this end, Lee <italic toggle="yes">et al</italic>[<xref rid="B94" ref-type="bibr">94</xref>] suggest using bioinformatics and molecular docking studies for scientists to identify specific bioactive compounds that may be interacting with receptors in liver cell lines. This approach can help optimize the therapeutic use of plant extracts.</p><p>Furthermore, most of the existing research studies on plant-based liver therapies are conducted on animal models, so the results cannot be directly extrapolated into human applications. The mechanistic understanding of such animal studies are valuable, but physiological differences when translating such data into clinical practice introduce difficulties. Human clinical trials should be conducted to confirm the efficacy seen in preclinical studies[<xref rid="B95" ref-type="bibr">95</xref>]. Future human studies need to be designed more robustly to ascertain the therapeutic efficacy of these compounds and their safety profiles in patients with liver diseases.</p><p>The escalating worldwide trends in liver diseases, such as NAFLD and fibrosis call for effective and accessible treatments. Plant-based therapies represent a promising development in complementary therapies in the possible additional mechanisms used concomitantly with conventional treatment approaches. Studies like those of Parama <italic toggle="yes">et al</italic>[<xref rid="B96" ref-type="bibr">96</xref>] and Surai[<xref rid="B97" ref-type="bibr">97</xref>] have shown the beneficial effects of compounds such as curcumin, silymarin, and berberine, including anti-inflammatory, antioxidant, and lipid-modulating activities that are foreseen to efficiently support liver function and slow disease progression. Thus, phytochemicals could prove helpful adjuncts for treating liver diseases, potentially working through a multi-targeted approach well adapted to the complex pathophysiology of chronic liver disorders.</p><p>Similarly, quercetin and naringenin are two flavonoids that have been proven by Du <italic toggle="yes">et al</italic>[<xref rid="B98" ref-type="bibr">98</xref>] to show anti-fibrotic properties, which are highly beneficial in treating liver fibrosis. The results conclude that the development of these plant-based compounds has a bright future in preventing liver damage and reversing pathological changes of chronic liver conditions. Therefore, the utilization of herbal-based therapies is increasingly becoming a promising choice for patients as supplements to conventional pharmaceutical drugs.</p><p>Concerning plant-based therapies on the aspect of liver health, there are encouraging findings based on existing literature. However, many studies have some reservations in terms of sample sizes and study designs. The methodologies adopted for research may vary considerably and have non-standardized protocols, which largely contribute to the inconsistencies between the studies. This makes it challenging to draw certain conclusions into clinical practice recommendations. Further, the long-term safety of these substances remains largely uninvestigated in patients with compromised liver functionality.</p></sec><sec><title>CONCLUSION</title><p>This bibliometric study reveals that the interest in a plant-based therapy for an optimal level of liver health is growing and continues to as advanced drug delivery technologies are developed. Large-scale and human-randomized further studies are recommended to validate the therapeutic value of these compounds. Standardization of extraction and formulation procedures is needed to ensure the results in different studies can be consistent. A multidisciplinary approach including pharmacology, molecular biology, and clinical trials is necessary to fully enable the therapeutic advantage of plant-based compounds. The therapies are destined to become integrated into standard treatment processes, hence reaching effective, accessible, and safe approaches to managing chronic disorders of the liver through further research and international cooperation.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>
<bold>Conflict-of-interest statement:</bold> The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></fn><fn><p>
<bold>PRISMA 2009 Checklist statement:</bold> The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.</p></fn><fn><p>
<bold>Provenance and peer review:</bold> Unsolicited article; Externally peer reviewed.</p></fn><fn><p>
<bold>Peer-review model:</bold> Single blind</p></fn><fn><p>
<bold>Specialty type:</bold> Gastroenterology and hepatology</p></fn><fn><p>
<bold>Country of origin:</bold> Kenya</p></fn><fn><p>
<bold>Peer-review report&#8217;s classification</bold>
</p></fn><fn><p>
<bold>Scientific Quality:</bold> Grade A, Grade B, Grade B</p></fn><fn><p>
<bold>Novelty:</bold> Grade A, Grade B, Grade B</p></fn><fn><p>
<bold>Creativity or Innovation:</bold> Grade B, Grade B, Grade B</p></fn><fn><p>
<bold>Scientific Significance:</bold> Grade A, Grade B, Grade B</p></fn><fn><p>
<bold>P-Reviewer:</bold> Yang T; Zhou X <bold>S-Editor:</bold> Qu XL <bold>L-Editor:</bold> Filipodia <bold>P-Editor:</bold> Zheng XM</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devarbhavi</surname><given-names>H</given-names></name><name name-style="western"><surname>Asrani</surname><given-names>SK</given-names></name><name name-style="western"><surname>Arab</surname><given-names>JP</given-names></name><name name-style="western"><surname>Nartey</surname><given-names>YA</given-names></name><name name-style="western"><surname>Pose</surname><given-names>E</given-names></name><name name-style="western"><surname>Kamath</surname><given-names>PS</given-names></name></person-group><article-title>Global burden of liver disease: 2023 update</article-title><source>J Hepatol</source><year>2023</year><volume>79</volume><fpage>516</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">36990226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jhep.2023.03.017</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheemerla</surname><given-names>S</given-names></name><name name-style="western"><surname>Balakrishnan</surname><given-names>M</given-names></name></person-group><article-title>Global Epidemiology of Chronic Liver Disease</article-title><source>Clin Liver Dis (Hoboken)</source><year>2021</year><volume>17</volume><fpage>365</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">34136143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cld.1061</pub-id><pub-id pub-id-type="pmcid">PMC8177826</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="webpage"><comment>Nonalcoholic Fatty Liver Disease (NAFLD). Fatty Liver Disease. 2022. Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://liverfoundation.org/about-your-liver/facts-about-liver-disease/fatty-liver-disease/">https://liverfoundation.org/about-your-liver/facts-about-liver-disease/fatty-liver-disease/</uri></comment></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>JD</given-names></name><name name-style="western"><surname>Hainaut</surname><given-names>P</given-names></name><name name-style="western"><surname>Gores</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Amadou</surname><given-names>A</given-names></name><name name-style="western"><surname>Plymoth</surname><given-names>A</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>LR</given-names></name></person-group><article-title>A global view of hepatocellular carcinoma: trends, risk, prevention and management</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2019</year><volume>16</volume><fpage>589</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">31439937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41575-019-0186-y</pub-id><pub-id pub-id-type="pmcid">PMC6813818</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samant</surname><given-names>H</given-names></name><name name-style="western"><surname>Amiri</surname><given-names>HS</given-names></name><name name-style="western"><surname>Zibari</surname><given-names>GB</given-names></name></person-group><article-title>Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management</article-title><source>J Gastrointest Oncol</source><year>2021</year><volume>12</volume><fpage>S361</fpage><lpage>S373</lpage><pub-id pub-id-type="pmid">34422400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/jgo.2020.02.08</pub-id><pub-id pub-id-type="pmcid">PMC8343080</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Younossi</surname><given-names>ZM</given-names></name><name name-style="western"><surname>Wong</surname><given-names>G</given-names></name><name name-style="western"><surname>Anstee</surname><given-names>QM</given-names></name><name name-style="western"><surname>Henry</surname><given-names>L</given-names></name></person-group><article-title>The Global Burden of Liver Disease</article-title><source>Clin Gastroenterol Hepatol</source><year>2023</year><volume>21</volume><fpage>1978</fpage><lpage>1991</lpage><pub-id pub-id-type="pmid">37121527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cgh.2023.04.015</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wazir</surname><given-names>H</given-names></name><name name-style="western"><surname>Abid</surname><given-names>M</given-names></name><name name-style="western"><surname>Essani</surname><given-names>B</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>H</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>Khan M</given-names></name><name name-style="western"><surname>Nasrullah</surname><given-names>F</given-names></name><name name-style="western"><surname>Qadeer</surname><given-names>U</given-names></name><name name-style="western"><surname>Khalid</surname><given-names>A</given-names></name><name name-style="western"><surname>Varrassi</surname><given-names>G</given-names></name><name name-style="western"><surname>Muzammil</surname><given-names>MA</given-names></name><name name-style="western"><surname>Maryam</surname><given-names>A</given-names></name><name name-style="western"><surname>Syed</surname><given-names>ARS</given-names></name><name name-style="western"><surname>Shah</surname><given-names>AA</given-names></name><name name-style="western"><surname>Kinger</surname><given-names>S</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>F</given-names></name></person-group><article-title>Diagnosis and Treatment of Liver Disease: Current Trends and Future Directions</article-title><source>Cureus</source><year>2023</year><volume>15</volume><fpage>e49920</fpage><pub-id pub-id-type="pmid">38174191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.49920</pub-id><pub-id pub-id-type="pmcid">PMC10763979</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>G</given-names></name></person-group><article-title>Management of liver diseases: Current perspectives</article-title><source>World J Gastroenterol</source><year>2022</year><volume>28</volume><fpage>5818</fpage><lpage>5826</lpage><pub-id pub-id-type="pmid">36353204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v28.i40.5818</pub-id><pub-id pub-id-type="pmcid">PMC9639658</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Cort&#233;s</surname><given-names>M</given-names></name><name name-style="western"><surname>Garc&#237;a-Garc&#237;a</surname><given-names>A</given-names></name></person-group><article-title>Management of Pharmacologic Adverse Effects in Advanced Liver Disease</article-title><source>Clin Drug Investig</source><year>2022</year><volume>42</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40261-022-01150-w</pub-id><pub-id pub-id-type="pmcid">PMC9205818</pub-id><pub-id pub-id-type="pmid">35522395</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Nagalli</surname><given-names>S</given-names></name></person-group><comment>Chronic Liver Disease. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-</comment><pub-id pub-id-type="pmid">32119484</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Xia</surname><given-names>L</given-names></name></person-group><article-title>Plant-derived natural products and combination therapy in liver cancer</article-title><source>Front Oncol</source><year>2023</year><volume>13</volume><fpage>1116532</fpage><pub-id pub-id-type="pmid">36865794</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fonc.2023.1116532</pub-id><pub-id pub-id-type="pmcid">PMC9971944</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mancak</surname><given-names>M</given-names></name><name name-style="western"><surname>Altintas</surname><given-names>D</given-names></name><name name-style="western"><surname>Balaban</surname><given-names>Y</given-names></name><name name-style="western"><surname>Caliskan</surname><given-names>UK</given-names></name></person-group><article-title>Evidence-based herbal treatments in liver diseases</article-title><source>Hepatol Forum</source><year>2024</year><volume>5</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">38283267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14744/hf.2022.2022.0052</pub-id><pub-id pub-id-type="pmcid">PMC10809338</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riaz</surname><given-names>M</given-names></name><name name-style="western"><surname>Khalid</surname><given-names>R</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>M</given-names></name><name name-style="western"><surname>Anjum</surname><given-names>F</given-names></name><name name-style="western"><surname>Fatima</surname><given-names>H</given-names></name><name name-style="western"><surname>Zia</surname><given-names>S</given-names></name><name name-style="western"><surname>Rasool</surname><given-names>G</given-names></name><name name-style="western"><surname>Egbuna</surname><given-names>C</given-names></name><name name-style="western"><surname>Mtewa</surname><given-names>AG</given-names></name><name name-style="western"><surname>Uche</surname><given-names>CZ</given-names></name><name name-style="western"><surname>Aslam</surname><given-names>MA</given-names></name></person-group><article-title>Phytobioactive compounds as therapeutic agents for human diseases: A review</article-title><source>Food Sci Nutr</source><year>2023</year><volume>11</volume><fpage>2500</fpage><lpage>2529</lpage><pub-id pub-id-type="pmid">37324906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/fsn3.3308</pub-id><pub-id pub-id-type="pmcid">PMC10261751</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>H</given-names></name><name name-style="western"><surname>Rao</surname><given-names>I</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>L</given-names></name><name name-style="western"><surname>Aati</surname><given-names>HY</given-names></name><name name-style="western"><surname>Aati</surname><given-names>S</given-names></name><name name-style="western"><surname>Zeeshan</surname><given-names>M</given-names></name><name name-style="western"><surname>Ur</surname><given-names>Rehman Khan K</given-names></name></person-group><article-title>Phytochemical analysis and bioactivity assessment of five medicinal plants from Pakistan: Exploring polyphenol contents, antioxidant potential, and antibacterial activities</article-title><source>Saudi J Biol Sci</source><year>2023</year><volume>30</volume><fpage>103783</fpage><pub-id pub-id-type="pmid">37680976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sjbs.2023.103783</pub-id><pub-id pub-id-type="pmcid">PMC10480623</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nwozo</surname><given-names>OS</given-names></name><name name-style="western"><surname>Effiong</surname><given-names>EM</given-names></name><name name-style="western"><surname>Aja</surname><given-names>PM</given-names></name><name name-style="western"><surname>Awuchi</surname><given-names>CG</given-names></name></person-group><article-title>Antioxidant, phytochemical, and therapeutic properties of medicinal plants: a review</article-title><source>Int J Food Prop</source><year>2023</year><volume>26</volume><fpage>359</fpage><lpage>388</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorrenti</surname><given-names>V</given-names></name><name name-style="western"><surname>Bur&#242;</surname><given-names>I</given-names></name><name name-style="western"><surname>Consoli</surname><given-names>V</given-names></name><name name-style="western"><surname>Vanella</surname><given-names>L</given-names></name></person-group><article-title>Recent Advances in Health Benefits of Bioactive Compounds from Food Wastes and By-Products: Biochemical Aspects</article-title><source>Int J Mol Sci</source><year>2023</year><volume>24</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms24032019</pub-id><pub-id pub-id-type="pmcid">PMC9916361</pub-id><pub-id pub-id-type="pmid">36768340</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahoo</surname><given-names>DK</given-names></name><name name-style="western"><surname>Wong</surname><given-names>D</given-names></name><name name-style="western"><surname>Patani</surname><given-names>A</given-names></name><name name-style="western"><surname>Paital</surname><given-names>B</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>VK</given-names></name><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><name name-style="western"><surname>Jergens</surname><given-names>AE</given-names></name></person-group><article-title>Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review</article-title><source>Front Cell Infect Microbiol</source><year>2024</year><volume>14</volume><fpage>1348713</fpage><pub-id pub-id-type="pmid">38510969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2024.1348713</pub-id><pub-id pub-id-type="pmcid">PMC10952105</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arroyave-Ospina</surname><given-names>JC</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Geng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Moshage</surname><given-names>H</given-names></name></person-group><article-title>Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy</article-title><source>Antioxidants (Basel)</source><year>2021</year><volume>10</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antiox10020174</pub-id><pub-id pub-id-type="pmcid">PMC7911109</pub-id><pub-id pub-id-type="pmid">33530432</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayoka</surname><given-names>TO</given-names></name><name name-style="western"><surname>Ezema</surname><given-names>BO</given-names></name><name name-style="western"><surname>Eze</surname><given-names>CN</given-names></name><name name-style="western"><surname>Nnadi</surname><given-names>CO</given-names></name></person-group><article-title>Antioxidants for the Prevention and Treatment of Non-communicable Diseases</article-title><source>J Explor Res Pharmacol</source><year>2022</year><volume>7</volume><fpage>179</fpage><lpage>189</lpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Tan</surname><given-names>HY</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Lao</surname><given-names>L</given-names></name><name name-style="western"><surname>Wong</surname><given-names>CW</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name></person-group><article-title>The Role of Oxidative Stress and Antioxidants in Liver Diseases</article-title><source>Int J Mol Sci</source><year>2015</year><volume>16</volume><fpage>26087</fpage><lpage>26124</lpage><pub-id pub-id-type="pmid">26540040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms161125942</pub-id><pub-id pub-id-type="pmcid">PMC4661801</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>H</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>H</given-names></name><name name-style="western"><surname>Nabavi</surname><given-names>SM</given-names></name></person-group><article-title>Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects</article-title><source>Food Chem Toxicol</source><year>2019</year><volume>124</volume><fpage>182</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">30529260</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fct.2018.12.002</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gajender</surname></name><name name-style="western"><surname>Mazumder</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Azad</surname><given-names>MAK</given-names></name></person-group><article-title>A Comprehensive Review of the Pharmacological Importance of Dietary Flavonoids as Hepatoprotective Agents</article-title><source>Evid Based Complement Alternat Med</source><year>2023</year><volume>2023</volume><fpage>4139117</fpage><pub-id pub-id-type="pmid">37123086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2023/4139117</pub-id><pub-id pub-id-type="pmcid">PMC10147524</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Ganguly</surname><given-names>R</given-names></name><name name-style="western"><surname>Singh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Rana</surname><given-names>HK</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>AK</given-names></name></person-group><article-title>Antioxidant, anti-inflammatory and hepatoprotective activities of Terminalia bellirica and its bioactive component ellagic acid against diclofenac induced oxidative stress and hepatotoxicity</article-title><source>Toxicol Rep</source><year>2021</year><volume>8</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">33391996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxrep.2020.12.010</pub-id><pub-id pub-id-type="pmcid">PMC7772792</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandey</surname><given-names>B</given-names></name><name name-style="western"><surname>Baral</surname><given-names>R</given-names></name><name name-style="western"><surname>Kaundinnyayana</surname><given-names>A</given-names></name><name name-style="western"><surname>Panta</surname><given-names>S</given-names></name></person-group><article-title>Promising hepatoprotective agents from the natural sources: a study of scientific evidence</article-title><source>Egypt Liver J</source><year>2023</year><volume>13</volume><fpage>14</fpage></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ezike</surname><given-names>TC</given-names></name><name name-style="western"><surname>Okpala</surname><given-names>US</given-names></name><name name-style="western"><surname>Onoja</surname><given-names>UL</given-names></name><name name-style="western"><surname>Nwike</surname><given-names>CP</given-names></name><name name-style="western"><surname>Ezeako</surname><given-names>EC</given-names></name><name name-style="western"><surname>Okpara</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Okoroafor</surname><given-names>CC</given-names></name><name name-style="western"><surname>Eze</surname><given-names>SC</given-names></name><name name-style="western"><surname>Kalu</surname><given-names>OL</given-names></name><name name-style="western"><surname>Odoh</surname><given-names>EC</given-names></name><name name-style="western"><surname>Nwadike</surname><given-names>UG</given-names></name><name name-style="western"><surname>Ogbodo</surname><given-names>JO</given-names></name><name name-style="western"><surname>Umeh</surname><given-names>BU</given-names></name><name name-style="western"><surname>Ossai</surname><given-names>EC</given-names></name><name name-style="western"><surname>Nwanguma</surname><given-names>BC</given-names></name></person-group><article-title>Advances in drug delivery systems, challenges and future directions</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e17488</fpage><pub-id pub-id-type="pmid">37416680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2023.e17488</pub-id><pub-id pub-id-type="pmcid">PMC10320272</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coelho</surname><given-names>JF</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>PC</given-names></name><name name-style="western"><surname>Alves</surname><given-names>P</given-names></name><name name-style="western"><surname>Cordeiro</surname><given-names>R</given-names></name><name name-style="western"><surname>Fonseca</surname><given-names>AC</given-names></name><name name-style="western"><surname>G&#243;is</surname><given-names>JR</given-names></name><name name-style="western"><surname>Gil</surname><given-names>MH</given-names></name></person-group><article-title>Drug delivery systems: Advanced technologies potentially applicable in personalized treatments</article-title><source>EPMA J</source><year>2010</year><volume>1</volume><fpage>164</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">23199049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13167-010-0001-x</pub-id><pub-id pub-id-type="pmcid">PMC3405312</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>N</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>S</given-names></name><name name-style="western"><surname>Behl</surname><given-names>T</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Anwer</surname><given-names>MK</given-names></name><name name-style="western"><surname>Vargas-De-La-Cruz</surname><given-names>C</given-names></name><name name-style="western"><surname>Bungau</surname><given-names>SG</given-names></name><name name-style="western"><surname>Brisc</surname><given-names>C</given-names></name></person-group><article-title>Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics</article-title><source>Molecules</source><year>2023</year><volume>28</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules28062811</pub-id><pub-id pub-id-type="pmcid">PMC10057127</pub-id><pub-id pub-id-type="pmid">36985782</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bonif&#225;cio</surname><given-names>BV</given-names></name><name name-style="western"><surname>Silva</surname><given-names>PB</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>MA</given-names></name><name name-style="western"><surname>Negri</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bauab</surname><given-names>TM</given-names></name><name name-style="western"><surname>Chorilli</surname><given-names>M</given-names></name></person-group><article-title>Nanotechnology-based drug delivery systems and herbal medicines: a review</article-title><source>Int J Nanomedicine</source><year>2014</year><volume>9</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S52634</pub-id><pub-id pub-id-type="pmcid">PMC3862741</pub-id><pub-id pub-id-type="pmid">24363556</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ezhilarasan</surname><given-names>D</given-names></name><name name-style="western"><surname>Shree</surname><given-names>Harini K</given-names></name></person-group><article-title>Nanodrug delivery: Strategies to circumvent nanoparticle trafficking by Kupffer cells in the liver</article-title><source>J Drug Deliv Sci Technol</source><year>2023</year><volume>86</volume><fpage>104731</fpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>R</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers</article-title><source>Heliyon</source><year>2024</year><volume>10</volume><fpage>e38165</fpage><pub-id pub-id-type="pmid">39364250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2024.e38165</pub-id><pub-id pub-id-type="pmcid">PMC11447355</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name name-style="western"><surname>PLGA</surname><given-names>Microspheres</given-names></name></person-group><comment>eSUNMed. Available from: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.esunmed.net/plga-microspheres-product/">https://www.esunmed.net/plga-microspheres-product/</uri></comment></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makadia</surname><given-names>HK</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>SJ</given-names></name></person-group><article-title>Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier</article-title><source>Polymers (Basel)</source><year>2011</year><volume>3</volume><fpage>1377</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">22577513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/polym3031377</pub-id><pub-id pub-id-type="pmcid">PMC3347861</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>A</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations</article-title><source>J Funct Foods</source><year>2023</year><volume>100</volume><fpage>105384</fpage></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di</surname><given-names>Costanzo A</given-names></name><name name-style="western"><surname>Angelico</surname><given-names>R</given-names></name></person-group><article-title>Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art</article-title><source>Molecules</source><year>2019</year><volume>24</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules24112155</pub-id><pub-id pub-id-type="pmcid">PMC6600503</pub-id><pub-id pub-id-type="pmid">31181687</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azadpour</surname><given-names>M</given-names></name><name name-style="western"><surname>Farajollahi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Dariushnejad</surname><given-names>H</given-names></name><name name-style="western"><surname>Varzi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Varezardi</surname><given-names>A</given-names></name><name name-style="western"><surname>Barati</surname><given-names>M</given-names></name></person-group><article-title>Effects of synthetic silymarin-PLGA nanoparticles on M2 polarization and inflammatory cytokines in LPS-treated murine peritoneal macrophages</article-title><source>Iran J Basic Med Sci</source><year>2021</year><volume>24</volume><fpage>1446</fpage><lpage>1454</lpage><pub-id pub-id-type="pmid">35096304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.22038/IJBMS.2021.59312.13161</pub-id><pub-id pub-id-type="pmcid">PMC8769520</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiyyad</surname><given-names>IM</given-names></name><name name-style="western"><surname>Bhambere</surname><given-names>D</given-names></name><name name-style="western"><surname>Kshirsagar</surname><given-names>S</given-names></name></person-group><article-title>Formulation and Optimization of Silymarin Loaded PLGA Nanoparticle for liver targeting</article-title><source>Asian J Pharm Technol</source><year>2017</year><volume>7</volume><fpage>209</fpage></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashfaq</surname><given-names>R</given-names></name><name name-style="western"><surname>Rasul</surname><given-names>A</given-names></name><name name-style="western"><surname>Asghar</surname><given-names>S</given-names></name><name name-style="western"><surname>Kov&#225;cs</surname><given-names>A</given-names></name><name name-style="western"><surname>Berk&#243;</surname><given-names>S</given-names></name><name name-style="western"><surname>Budai-Sz&#369;cs</surname><given-names>M</given-names></name></person-group><article-title>Lipid Nanoparticles: An Effective Tool to Improve the Bioavailability of Nutraceuticals</article-title><source>Int J Mol Sci</source><year>2023</year><volume>24</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms242115764</pub-id><pub-id pub-id-type="pmcid">PMC10648376</pub-id><pub-id pub-id-type="pmid">37958750</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghasemiyeh</surname><given-names>P</given-names></name><name name-style="western"><surname>Mohammadi-Samani</surname><given-names>S</given-names></name></person-group><article-title>Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages</article-title><source>Res Pharm Sci</source><year>2018</year><volume>13</volume><fpage>288</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">30065762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/1735-5362.235156</pub-id><pub-id pub-id-type="pmcid">PMC6040163</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhai</surname><given-names>J</given-names></name><name name-style="western"><surname>Tran</surname><given-names>N</given-names></name><name name-style="western"><surname>Mulet</surname><given-names>X</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>CJ</given-names></name></person-group><article-title>Lipid nanoparticle steric stabilization roadmap</article-title><source>Adv Biomembr Lipid Self-Assembly</source><year>2022</year><volume>35</volume><fpage>41</fpage><lpage>75</lpage></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lee</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>G</given-names></name></person-group><article-title>Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications</article-title><source>Int J Nanomedicine</source><year>2020</year><volume>15</volume><fpage>3099</fpage><lpage>3120</lpage><pub-id pub-id-type="pmid">32431504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S210320</pub-id><pub-id pub-id-type="pmcid">PMC7200256</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amjad</surname><given-names>S</given-names></name><name name-style="western"><surname>Serajuddin</surname><given-names>M</given-names></name></person-group><article-title>Nanoparticle Drug Delivery: An Advanced Approach for Highly Competent and Multifunctional Therapeutic Treatment</article-title><source>Model Control Drug Deliv Syst</source><year>2021</year><fpage>183</fpage><lpage>193</lpage></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumari</surname><given-names>A</given-names></name><name name-style="western"><surname>Singla</surname><given-names>R</given-names></name><name name-style="western"><surname>Guliani</surname><given-names>A</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>SK</given-names></name></person-group><article-title>Nanoencapsulation for drug delivery</article-title><source>EXCLI J</source><year>2014</year><volume>13</volume><fpage>265</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">26417260</pub-id><pub-id pub-id-type="pmcid">PMC4464443</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patra</surname><given-names>JK</given-names></name><name name-style="western"><surname>Das</surname><given-names>G</given-names></name><name name-style="western"><surname>Fraceto</surname><given-names>LF</given-names></name><name name-style="western"><surname>Campos</surname><given-names>EVR</given-names></name><name name-style="western"><surname>Rodriguez-Torres</surname><given-names>MDP</given-names></name><name name-style="western"><surname>Acosta-Torres</surname><given-names>LS</given-names></name><name name-style="western"><surname>Diaz-Torres</surname><given-names>LA</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>R</given-names></name><name name-style="western"><surname>Swamy</surname><given-names>MK</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Habtemariam</surname><given-names>S</given-names></name><name name-style="western"><surname>Shin</surname><given-names>HS</given-names></name></person-group><article-title>Nano based drug delivery systems: recent developments and future prospects</article-title><source>J Nanobiotechnology</source><year>2018</year><volume>16</volume><fpage>71</fpage><pub-id pub-id-type="pmid">30231877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-018-0392-8</pub-id><pub-id pub-id-type="pmcid">PMC6145203</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witika</surname><given-names>BA</given-names></name><name name-style="western"><surname>Makoni</surname><given-names>PA</given-names></name><name name-style="western"><surname>Matafwali</surname><given-names>SK</given-names></name><name name-style="western"><surname>Chabalenge</surname><given-names>B</given-names></name><name name-style="western"><surname>Mwila</surname><given-names>C</given-names></name><name name-style="western"><surname>Kalungia</surname><given-names>AC</given-names></name><name name-style="western"><surname>Nkanga</surname><given-names>CI</given-names></name><name name-style="western"><surname>Bapolisi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Walker</surname><given-names>RB</given-names></name></person-group><article-title>Biocompatibility of Biomaterials for Nanoencapsulation: Current Approaches</article-title><source>Nanomaterials (Basel)</source><year>2020</year><volume>10</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nano10091649</pub-id><pub-id pub-id-type="pmcid">PMC7557593</pub-id><pub-id pub-id-type="pmid">32842562</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alam</surname><given-names>M</given-names></name><name name-style="western"><surname>Rizwanullah</surname><given-names>M</given-names></name><name name-style="western"><surname>Mir</surname><given-names>SR</given-names></name><name name-style="western"><surname>Amin</surname><given-names>S</given-names></name></person-group><article-title>Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis</article-title><source>OpenNano</source><year>2023</year><volume>10</volume><fpage>100123</fpage></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaves</surname><given-names>MA</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>LS</given-names></name><name name-style="western"><surname>Baldino</surname><given-names>L</given-names></name><name name-style="western"><surname>Pinho</surname><given-names>SC</given-names></name><name name-style="western"><surname>Reverchon</surname><given-names>E</given-names></name></person-group><article-title>Current Applications of Liposomes for the Delivery of Vitamins: A Systematic Review</article-title><source>Nanomaterials (Basel)</source><year>2023</year><volume>13</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nano13091557</pub-id><pub-id pub-id-type="pmcid">PMC10180326</pub-id><pub-id pub-id-type="pmid">37177102</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Su</surname><given-names>R</given-names></name><name name-style="western"><surname>Nie</surname><given-names>S</given-names></name><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Moustaid-Moussa</surname><given-names>N</given-names></name></person-group><article-title>Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals</article-title><source>J Nutr Biochem</source><year>2014</year><volume>25</volume><fpage>363</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">24406273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jnutbio.2013.10.002</pub-id><pub-id pub-id-type="pmcid">PMC3959237</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dytrych</surname><given-names>P</given-names></name><name name-style="western"><surname>Kej&#237;k</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hajduch</surname><given-names>J</given-names></name><name name-style="western"><surname>Kapl&#225;nek</surname><given-names>R</given-names></name><name name-style="western"><surname>Vesel&#225;</surname><given-names>K</given-names></name><name name-style="western"><surname>Ku&#269;nirov&#225;</surname><given-names>K</given-names></name><name name-style="western"><surname>Skali&#269;kov&#225;</surname><given-names>M</given-names></name><name name-style="western"><surname>Venhauerov&#225;</surname><given-names>A</given-names></name><name name-style="western"><surname>Hoskovec</surname><given-names>D</given-names></name><name name-style="western"><surname>Mart&#225;sek</surname><given-names>P</given-names></name><name name-style="western"><surname>Jakubek</surname><given-names>M</given-names></name></person-group><article-title>Therapeutic potential and limitations of curcumin as antimetastatic agent</article-title><source>Biomed Pharmacother</source><year>2023</year><volume>163</volume><fpage>114758</fpage><pub-id pub-id-type="pmid">37141738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2023.114758</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farzaei</surname><given-names>MH</given-names></name><name name-style="western"><surname>Zobeiri</surname><given-names>M</given-names></name><name name-style="western"><surname>Parvizi</surname><given-names>F</given-names></name><name name-style="western"><surname>El-Senduny</surname><given-names>FF</given-names></name><name name-style="western"><surname>Marmouzi</surname><given-names>I</given-names></name><name name-style="western"><surname>Coy-Barrera</surname><given-names>E</given-names></name><name name-style="western"><surname>Naseri</surname><given-names>R</given-names></name><name name-style="western"><surname>Nabavi</surname><given-names>SM</given-names></name><name name-style="western"><surname>Rahimi</surname><given-names>R</given-names></name><name name-style="western"><surname>Abdollahi</surname><given-names>M</given-names></name></person-group><article-title>Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu10070855</pub-id><pub-id pub-id-type="pmcid">PMC6073929</pub-id><pub-id pub-id-type="pmid">29966389</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>MR</given-names></name><name name-style="western"><surname>Rauf</surname><given-names>A</given-names></name><name name-style="western"><surname>Akash</surname><given-names>S</given-names></name><name name-style="western"><surname>Trisha</surname><given-names>SI</given-names></name><name name-style="western"><surname>Nasim</surname><given-names>AH</given-names></name><name name-style="western"><surname>Akter</surname><given-names>M</given-names></name><name name-style="western"><surname>Dhar</surname><given-names>PS</given-names></name><name name-style="western"><surname>Ogaly</surname><given-names>HA</given-names></name><name name-style="western"><surname>Hemeg</surname><given-names>HA</given-names></name><name name-style="western"><surname>Wilairatana</surname><given-names>P</given-names></name><name name-style="western"><surname>Thiruvengadam</surname><given-names>M</given-names></name></person-group><article-title>Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives</article-title><source>Biomed Pharmacother</source><year>2024</year><volume>170</volume><fpage>116034</fpage><pub-id pub-id-type="pmid">38141282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2023.116034</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Allemailem</surname><given-names>KS</given-names></name><name name-style="western"><surname>Almatroodi</surname><given-names>SA</given-names></name><name name-style="western"><surname>Almatroudi</surname><given-names>A</given-names></name><name name-style="western"><surname>Rahmani</surname><given-names>AH</given-names></name></person-group><article-title>Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications</article-title><source>3 Biotech</source><year>2020</year><volume>10</volume><fpage>163</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13205-020-2144-3</pub-id><pub-id pub-id-type="pmcid">PMC7062946</pub-id><pub-id pub-id-type="pmid">32206497</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warner</surname><given-names>JB</given-names></name><name name-style="western"><surname>Guenthner</surname><given-names>SC</given-names></name><name name-style="western"><surname>Hardesty</surname><given-names>JE</given-names></name><name name-style="western"><surname>McClain</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Warner</surname><given-names>DR</given-names></name><name name-style="western"><surname>Kirpich</surname><given-names>IA</given-names></name></person-group><article-title>Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease</article-title><source>World J Gastroenterol</source><year>2022</year><volume>28</volume><fpage>5280</fpage><lpage>5299</lpage><pub-id pub-id-type="pmid">36185629</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v28.i36.5280</pub-id><pub-id pub-id-type="pmcid">PMC9521517</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaghmi</surname><given-names>A</given-names></name><name name-style="western"><surname>Drouin-Ouellet</surname><given-names>J</given-names></name><name name-style="western"><surname>Brambilla</surname><given-names>D</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>MA</given-names></name></person-group><article-title>Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies</article-title><source>Biomaterials</source><year>2021</year><volume>269</volume><fpage>120461</fpage><pub-id pub-id-type="pmid">33218788</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2020.120461</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghezzi</surname><given-names>M</given-names></name><name name-style="western"><surname>Pescina</surname><given-names>S</given-names></name><name name-style="western"><surname>Padula</surname><given-names>C</given-names></name><name name-style="western"><surname>Santi</surname><given-names>P</given-names></name><name name-style="western"><surname>Del</surname><given-names>Favero E</given-names></name><name name-style="western"><surname>Cant&#249;</surname><given-names>L</given-names></name><name name-style="western"><surname>Nicoli</surname><given-names>S</given-names></name></person-group><article-title>Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions</article-title><source>J Control Release</source><year>2021</year><volume>332</volume><fpage>312</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">33652113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2021.02.031</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Negut</surname><given-names>I</given-names></name><name name-style="western"><surname>Bita</surname><given-names>B</given-names></name></person-group><article-title>Polymeric Micellar Systems-A Special Emphasis on "Smart" Drug Delivery</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pharmaceutics15030976</pub-id><pub-id pub-id-type="pmcid">PMC10056703</pub-id><pub-id pub-id-type="pmid">36986837</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Ling</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name></person-group><article-title>Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs</article-title><source>J Drug Deliv</source><year>2013</year><volume>2013</volume><fpage>340315</fpage><pub-id pub-id-type="pmid">23936656</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/340315</pub-id><pub-id pub-id-type="pmcid">PMC3712247</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuperkar</surname><given-names>K</given-names></name><name name-style="western"><surname>Patel</surname><given-names>D</given-names></name><name name-style="western"><surname>Atanase</surname><given-names>LI</given-names></name><name name-style="western"><surname>Bahadur</surname><given-names>P</given-names></name></person-group><article-title>Amphiphilic Block Copolymers: Their Structures, and Self-Assembly to Polymeric Micelles and Polymersomes as Drug Delivery Vehicles</article-title><source>Polymers (Basel)</source><year>2022</year><volume>14</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/polym14214702</pub-id><pub-id pub-id-type="pmcid">PMC9657626</pub-id><pub-id pub-id-type="pmid">36365696</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Telange</surname><given-names>DR</given-names></name><name name-style="western"><surname>Kamdi</surname><given-names>S</given-names></name><name name-style="western"><surname>Hemke</surname><given-names>AT</given-names></name><name name-style="western"><surname>Pethe</surname><given-names>AM</given-names></name><name name-style="western"><surname>Lambole</surname><given-names>VB</given-names></name><name name-style="western"><surname>Telrandhe</surname><given-names>UB</given-names></name></person-group><article-title>Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic&#174; F127/Chitosan-Myristic Acid Mixed Micelles</article-title><source>Curr Drug Deliv</source><comment>2024</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/0115672018278618240304054731</pub-id><pub-id pub-id-type="pmid">38500282</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>S</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>A</given-names></name><name name-style="western"><surname>Attar</surname><given-names>F</given-names></name><name name-style="western"><surname>Bloukh</surname><given-names>SH</given-names></name><name name-style="western"><surname>Edis</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sharifi</surname><given-names>M</given-names></name><name name-style="western"><surname>Balali</surname><given-names>E</given-names></name><name name-style="western"><surname>Nemati</surname><given-names>F</given-names></name><name name-style="western"><surname>Derakhshankhah</surname><given-names>H</given-names></name><name name-style="western"><surname>Zeinabad</surname><given-names>HA</given-names></name><name name-style="western"><surname>Nabi</surname><given-names>F</given-names></name><name name-style="western"><surname>Khan</surname><given-names>RH</given-names></name><name name-style="western"><surname>Hao</surname><given-names>X</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hua</surname><given-names>L</given-names></name><name name-style="western"><surname>Ten</surname><given-names>Hagen TLM</given-names></name><name name-style="western"><surname>Falahati</surname><given-names>M</given-names></name></person-group><article-title>A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents</article-title><source>Biomed Pharmacother</source><year>2022</year><volume>146</volume><fpage>112531</fpage><pub-id pub-id-type="pmid">34906771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2021.112531</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaikwad</surname><given-names>SS</given-names></name><name name-style="western"><surname>Morade</surname><given-names>YY</given-names></name><name name-style="western"><surname>Kothule</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kshirsagar</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Laddha</surname><given-names>UD</given-names></name><name name-style="western"><surname>Salunkhe</surname><given-names>KS</given-names></name></person-group><article-title>Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><fpage>e16561</fpage><pub-id pub-id-type="pmid">37260890</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2023.e16561</pub-id><pub-id pub-id-type="pmcid">PMC10227328</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Hu</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Wang</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Cui</surname><given-names>YL</given-names></name></person-group><article-title>Antioxidant Activities of Quercetin and Its Complexes for Medicinal Application</article-title><source>Molecules</source><year>2019</year><volume>24</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/molecules24061123</pub-id><pub-id pub-id-type="pmcid">PMC6470739</pub-id><pub-id pub-id-type="pmid">30901869</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forman</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Targeting oxidative stress in disease: promise and limitations of antioxidant therapy</article-title><source>Nat Rev Drug Discov</source><year>2021</year><volume>20</volume><fpage>689</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">34194012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41573-021-00233-1</pub-id><pub-id pub-id-type="pmcid">PMC8243062</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herdiana</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wathoni</surname><given-names>N</given-names></name><name name-style="western"><surname>Shamsuddin</surname><given-names>S</given-names></name><name name-style="western"><surname>Muchtaridi</surname><given-names>M</given-names></name></person-group><article-title>Drug release study of the chitosan-based nanoparticles</article-title><source>Heliyon</source><year>2022</year><volume>8</volume><fpage>e08674</fpage><pub-id pub-id-type="pmid">35028457</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2021.e08674</pub-id><pub-id pub-id-type="pmcid">PMC8741465</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandal</surname><given-names>A</given-names></name><name name-style="western"><surname>Bisht</surname><given-names>R</given-names></name><name name-style="western"><surname>Rupenthal</surname><given-names>ID</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>AK</given-names></name></person-group><article-title>Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies</article-title><source>J Control Release</source><year>2017</year><volume>248</volume><fpage>96</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">28087407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jconrel.2017.01.012</pub-id><pub-id pub-id-type="pmcid">PMC5319397</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tzankova</surname><given-names>V</given-names></name><name name-style="western"><surname>Aluani</surname><given-names>D</given-names></name><name name-style="western"><surname>Kondeva-Burdina</surname><given-names>M</given-names></name><name name-style="western"><surname>Yordanov</surname><given-names>Y</given-names></name><name name-style="western"><surname>Odzhakov</surname><given-names>F</given-names></name><name name-style="western"><surname>Apostolov</surname><given-names>A</given-names></name><name name-style="western"><surname>Yoncheva</surname><given-names>K</given-names></name></person-group><article-title>Hepatoprotective and antioxidant activity of quercetin loaded chitosan/alginate particles in vitro and in vivo in a model of paracetamol-induced toxicity</article-title><source>Biomed Pharmacother</source><year>2017</year><volume>92</volume><fpage>569</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">28577496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2017.05.008</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>XH</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>JQ</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>YZ</given-names></name><name name-style="western"><surname>Yan</surname><given-names>PY</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y</given-names></name></person-group><article-title>Novel nano-drug delivery system for natural products and their application</article-title><source>Pharmacol Res</source><year>2024</year><volume>201</volume><fpage>107100</fpage><pub-id pub-id-type="pmid">38341055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2024.107100</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>R</given-names></name><name name-style="western"><surname>Lillard</surname><given-names>JW Jr</given-names></name></person-group><article-title>Nanoparticle-based targeted drug delivery</article-title><source>Exp Mol Pathol</source><year>2009</year><volume>86</volume><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">19186176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yexmp.2008.12.004</pub-id><pub-id pub-id-type="pmcid">PMC3249419</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaou</surname><given-names>N</given-names></name><name name-style="western"><surname>Stavropoulou</surname><given-names>E</given-names></name><name name-style="western"><surname>Voidarou</surname><given-names>C</given-names></name><name name-style="western"><surname>Tsigalou</surname><given-names>C</given-names></name><name name-style="western"><surname>Bezirtzoglou</surname><given-names>E</given-names></name></person-group><article-title>Towards Advances in Medicinal Plant Antimicrobial Activity: A Review Study on Challenges and Future Perspectives</article-title><source>Microorganisms</source><year>2021</year><volume>9</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/microorganisms9102041</pub-id><pub-id pub-id-type="pmcid">PMC8541629</pub-id><pub-id pub-id-type="pmid">34683362</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ndezo</surname><given-names>Bisso B</given-names></name><name name-style="western"><surname>Njikang</surname><given-names>Epie Nkwelle R</given-names></name><name name-style="western"><surname>Tchuenguem</surname><given-names>Tchuenteu R</given-names></name><name name-style="western"><surname>Dzoyem</surname><given-names>JP</given-names></name></person-group><article-title>Phytochemical Screening, Antioxidant, and Antimicrobial Activities of Seven Underinvestigated Medicinal Plants against Microbial Pathogens</article-title><source>Adv Pharmacol Pharm Sci</source><year>2022</year><volume>2022</volume><fpage>1998808</fpage><pub-id pub-id-type="pmid">36263083</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2022/1998808</pub-id><pub-id pub-id-type="pmcid">PMC9576442</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muntean</surname><given-names>D</given-names></name><name name-style="western"><surname>Vulpie</surname><given-names>S</given-names></name></person-group><article-title>Antioxidant and Antibacterial Activity of Plant Extracts</article-title><source>Antibiotics (Basel)</source><year>2023</year><volume>12</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics12071176</pub-id><pub-id pub-id-type="pmcid">PMC10376182</pub-id><pub-id pub-id-type="pmid">37508272</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gheorghe</surname><given-names>G</given-names></name><name name-style="western"><surname>Stoian</surname><given-names>AP</given-names></name><name name-style="western"><surname>Gaman</surname><given-names>M</given-names></name><name name-style="western"><surname>Socea</surname><given-names>B</given-names></name><name name-style="western"><surname>Neagu</surname><given-names>TP</given-names></name><name name-style="western"><surname>Stanescu</surname><given-names>AMA</given-names></name><name name-style="western"><surname>Bratu</surname><given-names>OG</given-names></name><name name-style="western"><surname>Mischianu</surname><given-names>DLD</given-names></name><name name-style="western"><surname>Suceveanu</surname><given-names>AI</given-names></name><name name-style="western"><surname>Diaconu</surname><given-names>CC</given-names></name></person-group><article-title>The Benefits and Risks of Antioxidant Treatment in Liver Diseases</article-title><source>Rev Chim</source><year>2019</year><volume>70</volume><fpage>651</fpage><lpage>655</lpage></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matotoka</surname><given-names>MM</given-names></name><name name-style="western"><surname>Mashabela</surname><given-names>GT</given-names></name><name name-style="western"><surname>Masoko</surname><given-names>P</given-names></name></person-group><article-title>Phytochemical Content, Antibacterial Activity, and Antioxidant, Anti-Inflammatory, and Cytotoxic Effects of Traditional Medicinal Plants against Respiratory Tract Bacterial Pathogens</article-title><source>Evid Based Complement Alternat Med</source><year>2023</year><volume>2023</volume><fpage>1243438</fpage><pub-id pub-id-type="pmid">37293600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2023/1243438</pub-id><pub-id pub-id-type="pmcid">PMC10247327</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sweileh</surname><given-names>WM</given-names></name></person-group><article-title>Bibliometric analysis of peer-reviewed literature on climate change and human health with an emphasis on infectious diseases</article-title><source>Global Health</source><year>2020</year><volume>16</volume><fpage>44</fpage><pub-id pub-id-type="pmid">32384901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12992-020-00576-1</pub-id><pub-id pub-id-type="pmcid">PMC7206222</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falagas</surname><given-names>ME</given-names></name><name name-style="western"><surname>Pitsouni</surname><given-names>EI</given-names></name><name name-style="western"><surname>Malietzis</surname><given-names>GA</given-names></name><name name-style="western"><surname>Pappas</surname><given-names>G</given-names></name></person-group><article-title>Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses</article-title><source>FASEB J</source><year>2008</year><volume>22</volume><fpage>338</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">17884971</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.07-9492LSF</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aria</surname><given-names>M</given-names></name><name name-style="western"><surname>Cuccurullo</surname><given-names>C</given-names></name></person-group><article-title>bibliometrix: An R-tool for comprehensive science mapping analysis</article-title><source>J Informetr</source><year>2017</year><volume>11</volume><fpage>959</fpage><lpage>975</lpage></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>P</given-names></name><name name-style="western"><surname>Quadri</surname><given-names>K</given-names></name><name name-style="western"><surname>Kadian</surname><given-names>R</given-names></name><name name-style="western"><surname>Waziri</surname><given-names>A</given-names></name><name name-style="western"><surname>Agrawal</surname><given-names>P</given-names></name><name name-style="western"><surname>Alam</surname><given-names>MS</given-names></name></person-group><article-title>New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products</article-title><source> Iliver</source><year>2024</year><volume>3</volume><fpage>100131</fpage></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>K</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>JK</given-names></name><name name-style="western"><surname>Jain</surname><given-names>D</given-names></name><name name-style="western"><surname>Chaudhary</surname><given-names>AN</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>MC</given-names></name><name name-style="western"><surname>Singh</surname><given-names>B</given-names></name></person-group><article-title>Unveiling the therapeutic potential of traditional Chinese medicine Rhizome Coptidis: A comprehensive review</article-title><source>Pharmacol Res-Mod Chin Med</source><year>2024</year><volume>13</volume><fpage>100522</fpage></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asl</surname><given-names>MN</given-names></name><name name-style="western"><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds</article-title><source>Phytother Res</source><year>2008</year><volume>22</volume><fpage>709</fpage><lpage>724</lpage><pub-id pub-id-type="pmid">18446848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ptr.2362</pub-id><pub-id pub-id-type="pmcid">PMC7167813</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bagchi</surname><given-names>D</given-names></name><name name-style="western"><surname>Bagchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Stohs</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Das</surname><given-names>DK</given-names></name><name name-style="western"><surname>Ray</surname><given-names>SD</given-names></name><name name-style="western"><surname>Kuszynski</surname><given-names>CA</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>SS</given-names></name><name name-style="western"><surname>Pruess</surname><given-names>HG</given-names></name></person-group><article-title>Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention</article-title><source>Toxicology</source><year>2000</year><volume>148</volume><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">10962138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-483x(00)00210-9</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yeung</surname><given-names>RY</given-names></name><name name-style="western"><surname>Lin</surname><given-names>KF</given-names></name><name name-style="western"><surname>Li</surname><given-names>RC</given-names></name></person-group><article-title>Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model</article-title><source>Planta Med</source><year>2000</year><volume>66</volume><fpage>521</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">10985077</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-2000-11202</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khandel</surname><given-names>P</given-names></name><name name-style="western"><surname>Yadaw</surname><given-names>RK</given-names></name><name name-style="western"><surname>Soni</surname><given-names>DK</given-names></name><name name-style="western"><surname>Kanwar</surname><given-names>L</given-names></name><name name-style="western"><surname>Shahi</surname><given-names>SK</given-names></name></person-group><article-title>Biogenesis of metal nanoparticles and their pharmacological applications: present status and application prospects</article-title><source>J Nanostruct Chem</source><year>2018</year><volume>8</volume><fpage>217</fpage><lpage>254</lpage></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abenavoli</surname><given-names>L</given-names></name><name name-style="western"><surname>Izzo</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mili&#263;</surname><given-names>N</given-names></name><name name-style="western"><surname>Cicala</surname><given-names>C</given-names></name><name name-style="western"><surname>Santini</surname><given-names>A</given-names></name><name name-style="western"><surname>Capasso</surname><given-names>R</given-names></name></person-group><article-title>Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases</article-title><source>Phytother Res</source><year>2018</year><volume>32</volume><fpage>2202</fpage><lpage>2213</lpage><pub-id pub-id-type="pmid">30080294</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ptr.6171</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Webster</surname><given-names>D</given-names></name><name name-style="western"><surname>Cao</surname><given-names>J</given-names></name><name name-style="western"><surname>Shao</surname><given-names>A</given-names></name></person-group><article-title>The safety of green tea and green tea extract consumption in adults - Results of a systematic review</article-title><source>Regul Toxicol Pharmacol</source><year>2018</year><volume>95</volume><fpage>412</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">29580974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yrtph.2018.03.019</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>S</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wei</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M</given-names></name><name name-style="western"><surname>Su</surname><given-names>S</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Duan</surname><given-names>JA</given-names></name></person-group><article-title>Pharmacokinetic Comparisons of Multiple Triterpenic Acids from Jujubae Fructus Extract Following Oral Delivery in Normal and Acute Liver Injury Rats</article-title><source>Int J Mol Sci</source><year>2018</year><volume>19</volume><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms19072047</pub-id><pub-id pub-id-type="pmcid">PMC6073449</pub-id><pub-id pub-id-type="pmid">30011885</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Daim</surname><given-names>M</given-names></name><name name-style="western"><surname>Abushouk</surname><given-names>AI</given-names></name><name name-style="western"><surname>Reggi</surname><given-names>R</given-names></name><name name-style="western"><surname>Yarla</surname><given-names>NS</given-names></name><name name-style="western"><surname>Palmery</surname><given-names>M</given-names></name><name name-style="western"><surname>Peluso</surname><given-names>I</given-names></name></person-group><article-title>Association of antioxidant nutraceuticals and acetaminophen (paracetamol): Friend or foe?</article-title><source>J Food Drug Anal</source><year>2018</year><volume>26</volume><fpage>S78</fpage><lpage>S87</lpage><pub-id pub-id-type="pmid">29703389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jfda.2017.11.004</pub-id><pub-id pub-id-type="pmcid">PMC9326882</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bishayee</surname><given-names>A</given-names></name><name name-style="western"><surname>Darvesh</surname><given-names>AS</given-names></name><name name-style="western"><surname>Politis</surname><given-names>T</given-names></name><name name-style="western"><surname>McGory</surname><given-names>R</given-names></name></person-group><article-title>Resveratrol and liver disease: from bench to bedside and community</article-title><source>Liver Int</source><year>2010</year><volume>30</volume><fpage>1103</fpage><lpage>1114</lpage><pub-id pub-id-type="pmid">20557453</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1478-3231.2010.02295.x</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bharti</surname><given-names>S</given-names></name><name name-style="western"><surname>Rani</surname><given-names>N</given-names></name><name name-style="western"><surname>Krishnamurthy</surname><given-names>B</given-names></name><name name-style="western"><surname>Arya</surname><given-names>DS</given-names></name></person-group><article-title>Preclinical evidence for the pharmacological actions of naringin: a review</article-title><source>Planta Med</source><year>2014</year><volume>80</volume><fpage>437</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">24710903</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0034-1368351</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Egbuna</surname><given-names>C</given-names></name><name name-style="western"><surname>Patrick-Iwuanyanwu</surname><given-names>KC</given-names></name><name name-style="western"><surname>Onyeike</surname><given-names>EN</given-names></name><name name-style="western"><surname>Khan</surname><given-names>J</given-names></name><name name-style="western"><surname>Palai</surname><given-names>S</given-names></name><name name-style="western"><surname>Patel</surname><given-names>SB</given-names></name><name name-style="western"><surname>Parmar</surname><given-names>VK</given-names></name><name name-style="western"><surname>Kushwaha</surname><given-names>G</given-names></name><name name-style="western"><surname>Singh</surname><given-names>O</given-names></name><name name-style="western"><surname>Jeevanandam</surname><given-names>J</given-names></name><name name-style="western"><surname>Kumarasamy</surname><given-names>S</given-names></name><name name-style="western"><surname>Uche</surname><given-names>CZ</given-names></name><name name-style="western"><surname>Narayanan</surname><given-names>M</given-names></name><name name-style="western"><surname>Rudrapal</surname><given-names>M</given-names></name><name name-style="western"><surname>Odoh</surname><given-names>U</given-names></name><name name-style="western"><surname>Chikeokwu</surname><given-names>I</given-names></name><name name-style="western"><surname>G&#259;man</surname><given-names>MA</given-names></name><name name-style="western"><surname>Saravanan</surname><given-names>K</given-names></name><name name-style="western"><surname>Ifemeje</surname><given-names>JC</given-names></name><name name-style="western"><surname>Ezzat</surname><given-names>SM</given-names></name><name name-style="western"><surname>Olisah</surname><given-names>MC</given-names></name><name name-style="western"><surname>Chikwendu</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Adedokun</surname><given-names>KA</given-names></name><name name-style="western"><surname>Imodoye</surname><given-names>SO</given-names></name><name name-style="western"><surname>Bello</surname><given-names>IO</given-names></name><name name-style="western"><surname>Twinomuhwezi</surname><given-names>H</given-names></name><name name-style="western"><surname>Awuchi</surname><given-names>CG</given-names></name></person-group><article-title>Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic review</article-title><source>Food Sci Nutr</source><year>2023</year><volume>11</volume><fpage>4191</fpage><lpage>4210</lpage><pub-id pub-id-type="pmid">37457145</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/fsn3.3420</pub-id><pub-id pub-id-type="pmcid">PMC10345688</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cozma</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mandea</surname><given-names>M</given-names></name><name name-style="western"><surname>Diaconu</surname><given-names>CC</given-names></name></person-group><article-title>Drug-induced liver injury: toxins and antidotes</article-title><source>Antidotes to Toxins and Drugs</source><year>2024</year><fpage>195</fpage><lpage>220</lpage></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>MY</given-names></name><name name-style="western"><surname>Prabahar</surname><given-names>K</given-names></name><name name-style="western"><surname>G&#259;man</surname><given-names>MA</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>JL</given-names></name></person-group><article-title>Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta-analysis on randomized controlled trials</article-title><source>J Dig Dis</source><year>2023</year><volume>24</volume><fpage>380</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">37503812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1751-2980.13210</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuppusamy</surname><given-names>P</given-names></name><name name-style="western"><surname>Yusoff</surname><given-names>MM</given-names></name><name name-style="western"><surname>Maniam</surname><given-names>GP</given-names></name><name name-style="western"><surname>Govindan</surname><given-names>N</given-names></name></person-group><article-title>Biosynthesis of metallic nanoparticles using plant derivatives and their new avenues in pharmacological applications - An updated report</article-title><source>Saudi Pharm J</source><year>2016</year><volume>24</volume><fpage>473</fpage><lpage>484</lpage><pub-id pub-id-type="pmid">27330378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsps.2014.11.013</pub-id><pub-id pub-id-type="pmcid">PMC4908060</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Isbrucker</surname><given-names>RA</given-names></name><name name-style="western"><surname>Burdock</surname><given-names>GA</given-names></name></person-group><article-title>Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin</article-title><source>Regul Toxicol Pharmacol</source><year>2006</year><volume>46</volume><fpage>167</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">16884839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.yrtph.2006.06.002</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weng</surname><given-names>W</given-names></name><name name-style="western"><surname>Gao</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>New Insights for Cellular and Molecular Mechanisms of Aging and Aging-Related Diseases: Herbal Medicine as Potential Therapeutic Approach</article-title><source>Oxid Med Cell Longev</source><year>2019</year><volume>2019</volume><fpage>4598167</fpage><pub-id pub-id-type="pmid">31915506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2019/4598167</pub-id><pub-id pub-id-type="pmcid">PMC6930799</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name><name name-style="western"><surname>Jung</surname><given-names>JK</given-names></name><name name-style="western"><surname>Han</surname><given-names>SB</given-names></name><name name-style="western"><surname>Hong</surname><given-names>JT</given-names></name></person-group><article-title>Therapeutic applications of compounds in the Magnolia family</article-title><source>Pharmacol Ther</source><year>2011</year><volume>130</volume><fpage>157</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">21277893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pharmthera.2011.01.010</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamal</surname><given-names>MA</given-names></name><name name-style="western"><surname>Greig</surname><given-names>NH</given-names></name></person-group><article-title>Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C))</article-title><source>Curr Pharm Des</source><year>2016</year><volume>22</volume><fpage>4337</fpage><lpage>4340</lpage><pub-id pub-id-type="pmid">27655557</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1381612822999160719150757</pub-id><pub-id pub-id-type="pmcid">PMC5878040</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parama</surname><given-names>D</given-names></name><name name-style="western"><surname>Boruah</surname><given-names>M</given-names></name><name name-style="western"><surname>Yachna</surname><given-names>K</given-names></name><name name-style="western"><surname>Rana</surname><given-names>V</given-names></name><name name-style="western"><surname>Banik</surname><given-names>K</given-names></name><name name-style="western"><surname>Harsha</surname><given-names>C</given-names></name><name name-style="western"><surname>Thakur</surname><given-names>KK</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>U</given-names></name><name name-style="western"><surname>Arya</surname><given-names>A</given-names></name><name name-style="western"><surname>Mao</surname><given-names>X</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>KS</given-names></name><name name-style="western"><surname>Kunnumakkara</surname><given-names>AB</given-names></name></person-group><article-title>Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases</article-title><source>Life Sci</source><year>2020</year><volume>260</volume><fpage>118182</fpage><pub-id pub-id-type="pmid">32781063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.118182</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Surai</surname><given-names>PF</given-names></name></person-group><article-title>Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives</article-title><source>Antioxidants (Basel)</source><year>2015</year><volume>4</volume><fpage>204</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">26785346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antiox4010204</pub-id><pub-id pub-id-type="pmcid">PMC4665566</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Q</given-names></name></person-group><article-title>Naringenin: A Promising Therapeutic Agent against Organ Fibrosis</article-title><source>Oxid Med Cell Longev</source><year>2021</year><fpage>2021: 1210675</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2021/1210675</pub-id><pub-id pub-id-type="pmcid">PMC8601819</pub-id><pub-id pub-id-type="pmid">34804359</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>